Prescription and Over-the-Counter Drug Product List

37TH EDITION
Cumulative Supplement Number 12 : December 2017
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ACETAMINOPHEN; BUTALBITAL

CAPSULE;ORAL

>A> BUTALBITAL AND ACETAMINOPHEN

>A> MIKART INC 300MG;50MG
A 207313 001 Dec 27, 2017 Dec NEWA

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

CAPSULE;ORAL

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

>D> AB ! NEXGEN PHARMA 300MG;50MG;40MG
A 040885 001 Nov 16, 2009 Dec CTEC

>A> AA ! 300MG;50MG;40MG
A 040885 001 Nov 16, 2009 Dec CTEC

TABLET;ORAL

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

>D> AA MALLINCKRODT INC 325MG;50MG;40MG
A 087804 001 Jan 24, 1985 Dec CAHN

>A> AA SPECGX LLC 325MG;50MG;40MG
A 087804 001 Jan 24, 1985 Dec CAHN

ACETAMINOPHEN; CODEINE PHOSPHATE

SOLUTION;ORAL

ACETAMINOPHEN AND CODEINE PHOSPHATE

>D> AA WOCKHARDT 120MG/5ML;12MG/5ML
A 087006 001 Jul 22, 1981 Dec CAHN

>A> AA WOCKHARDT BIO AG 120MG/5ML;12MG/5ML
A 087006 001 Jul 22, 1981 Dec CAHN

TABLET;ORAL

ACETAMINOPHEN AND CODEINE PHOSPHATE

>D> AA ! MALLINCKRODT INC 300MG;15MG
A 040419 001 May 31, 2001 Dec CAHN

>D> AA 300MG;30MG
A 040419 002 May 31, 2001 Dec CAHN

>D> AA 300MG;60MG
A 040419 003 May 31, 2001 Dec CAHN

>A> AA ! SPECGX LLC 300MG;15MG
A 040419 001 May 31, 2001 Dec CAHN

>A> AA 300MG;30MG
A 040419 002 May 31, 2001 Dec CAHN

>A> AA 300MG;60MG
A 040419 003 May 31, 2001 Dec CAHN

ACETAMINOPHEN; HYDROCODONE BITARTRATE

TABLET;ORAL

ANEXSIA 5/325

>D> AA MALLINCKRODT 325MG;5MG

A 040409 001 Oct 20, 2000 Dec CAHN

>A> AA SPECGX LLC 325MG;5MG
A 040409 001 Oct 20, 2000 Dec CAHN

ANEXSIA 7.5/325

>D> AA MALLINCKRODT 325MG;7.5MG

A 040405 001 Sep 08, 2000 Dec CAHN

>A> AA SPECGX LLC 325MG;7.5MG
A 040405 001 Sep 08, 2000 Dec CAHN

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

>D> AA MALLINCKRODT 325MG;10MG
A 040400 001 Jul 26, 2000 Dec CAHN

>D> AA MALLINCKRODT INC 300MG;5MG
A 206718 001 Mar 31, 2017 Dec CAHN

>D> AA 300MG;7.5MG
A 206718 002 Mar 31, 2017 Dec CAHN

>D> AA 300MG;10MG
A 206718 003 Mar 31, 2017 Dec CAHN

>A> AA SPECGX LLC 300MG;5MG
A 206718 001 Mar 31, 2017 Dec CAHN

>A> AA 300MG;7.5MG
A 206718 002 Mar 31, 2017 Dec CAHN

>A> AA 300MG;10MG
A 206718 003 Mar 31, 2017 Dec CAHN

>A> AA 325MG;10MG
A 040400 001 Jul 26, 2000 Dec CAHN

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

SOLUTION;ORAL

OXYCODONE AND ACETAMINOPHEN

>D> AA ! MALLINCKRODT INC 325MG/5ML;5MG/5ML
A 040680 001 Sep 29, 2006 Dec CAHN

>A> AA ! SPECGX LLC 325MG/5ML;5MG/5ML
A 040680 001 Sep 29, 2006 Dec CAHN

TABLET;ORAL

OXYCET

>D> AA MALLINCKRODT 325MG;5MG
A 087463 001 Dec 07, 1983 Dec CAHN

>A> AA SPECGX LLC 325MG;5MG
A 087463 001 Dec 07, 1983 Dec CAHN

OXYCODONE AND ACETAMINOPHEN

>D> AA MALLINCKRODT 325MG;7.5MG
A 040545 001 Jun 30, 2004 Dec CAHN

>D> AA 325MG;10MG
A 040545 002 Jun 30, 2004 Dec CAHN

>A> AA NESHER PHARMS 325MG;2.5MG
A 210079 001 Dec 28, 2017 Dec NEWA

>A> AA 325MG;5MG
A 210079 002 Dec 28, 2017 Dec NEWA

>A> AA 325MG;7.5MG
A 210079 003 Dec 28, 2017 Dec NEWA

>A> AA 325MG;10MG
A 210079 004 Dec 28, 2017 Dec NEWA

>A> AA SPECGX LLC 325MG;7.5MG
A 040545 001 Jun 30, 2004 Dec CAHN

>A> AA 325MG;10MG
A 040545 002 Jun 30, 2004 Dec CAHN

Page 1 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ACETIC ACID, GLACIAL

SOLUTION/DROPS;OTIC

ACETIC ACID

>D> AT ! WOCKHARDT 2% A 040166 001 Jul 26, 1996 Dec CAHN

>A> AT ! WOCKHARDT BIO AG 2% A 040166 001 Jul 26, 1996 Dec CAHN

ACYCLOVIR SODIUM

INJECTABLE;INJECTION

ACYCLOVIR SODIUM

>D> AP MYLAN LABS LTD EQ 500MG BASE/VIAL A 203927 001 Mar 29, 2017 Dec DISC

>A> @ EQ 500MG BASE/VIAL A 203927 001 Mar 29, 2017 Dec DISC

>D> AP EQ 1GM BASE/VIAL A 203927 002 Mar 29, 2017 Dec DISC

>A> @ EQ 1GM BASE/VIAL A 203927 002 Mar 29, 2017 Dec DISC

ALBUTEROL SULFATE

TABLET;ORAL

ALBUTEROL SULFATE

>A> @ FOSUN PHARMA EQ 2MG BASE A 072151 001 Dec 05, 1989 Dec CAHN

>A> @ EQ 4MG BASE A 072152 001 Dec 05, 1989 Dec CAHN

>D> @ SANDOZ EQ 2MG BASE A 072151 001 Dec 05, 1989 Dec CAHN

>D> @ EQ 4MG BASE A 072152 001 Dec 05, 1989 Dec CAHN

AMANTADINE HYDROCHLORIDE

SYRUP;ORAL

AMANTADINE HYDROCHLORIDE

>D> AA ! WOCKHARDT 50MG/5ML A 075060 001 Dec 24, 1998 Dec CAHN

>A> AA ! WOCKHARDT BIO AG 50MG/5ML A 075060 001 Dec 24, 1998 Dec CAHN

AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

TABLET;ORAL

AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

>A> @ FOSUN PHARMA EQ 5MG ANHYDROUS;50MG A 073357 001 Nov 27, 1991 Dec CAHN

>D> @ SANDOZ EQ 5MG ANHYDROUS;50MG A 073357 001 Nov 27, 1991 Dec CAHN

AMIODARONE HYDROCHLORIDE

TABLET;ORAL

AMIODARONE HYDROCHLORIDE

>A> AB MAYNE PHARMA INC 100MG A 075389 002 Dec 28, 2017 Dec NEWA

>A> AB 400MG A 075389 003 Dec 28, 2017 Dec NEWA

AMLODIPINE BESYLATE

TABLET;ORAL

AMLODIPINE BESYLATE

>A> @ FOSUN PHARMA EQ 2.5MG BASE A 076859 001 Sep 10, 2007 Dec CAHN

>A> @ EQ 5MG BASE A 076859 002 Sep 10, 2007 Dec CAHN

>A> @ EQ 10MG BASE A 076859 003 Sep 10, 2007 Dec CAHN

>D> @ SANDOZ EQ 2.5MG BASE A 076859 001 Sep 10, 2007 Dec CAHN

>D> @ EQ 5MG BASE A 076859 002 Sep 10, 2007 Dec CAHN

>D> @ EQ 10MG BASE A 076859 003 Sep 10, 2007 Dec CAHN

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

TABLET;ORAL

AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

>A> AB AUROBINDO PHARMA LTD 5MG;12.5MG;160MG A 206180 001 Dec 19, 2017 Dec NEWA

>A> AB 5MG;25MG;160MG A 206180 002 Dec 19, 2017 Dec NEWA

>A> AB 10MG;12.5MG;160MG A 206180 003 Dec 19, 2017 Dec NEWA

>A> AB 10MG;25MG;160MG A 206180 004 Dec 19, 2017 Dec NEWA

>A> AB 10MG;25MG;320MG A 206180 005 Dec 19, 2017 Dec NEWA

AMLODIPINE BESYLATE; PERINDOPRIL ARGININE

TABLET;ORAL

PRESTALIA

>A> + MARINA BIOTECH EQ 2.5MG BASE;3.5MG N 205003 001 Jan 21, 2015 Dec CAHN

>A> + EQ 5MG BASE;7MG N 205003 002 Jan 21, 2015 Dec CAHN

>A> +! EQ 10MG BASE;14MG N 205003 003 Jan 21, 2015 Dec CAHN

>D> + SYMPLMED PHARMS LLC EQ 2.5MG BASE;3.5MG N 205003 001 Jan 21, 2015 Dec CAHN

>D> + EQ 5MG BASE;7MG N 205003 002 Jan 21, 2015 Dec CAHN

>D> +! EQ 10MG BASE;14MG N 205003 003 Jan 21, 2015 Dec CAHN

Page 2 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

AMOXICILLIN

FOR SUSPENSION;ORAL

AMOXICILLIN

>D> AB WOCKHARDT 400MG/5ML A 065319 002 Jun 18, 2007 Dec CAHN

>A> AB WOCKHARDT BIO AG 400MG/5ML A 065319 002 Jun 18, 2007 Dec CAHN

AMOXICILLIN; CLAVULANATE POTASSIUM

FOR SUSPENSION;ORAL

AMOXICILLIN AND CLAVULANATE POTASSIUM

>D> AB WOCKHARDT 250MG/5ML;EQ 62.5MG BASE/5ML A 065431 001 Nov 25, 2008 Dec CAHN

>A> AB WOCKHARDT BIO AG 250MG/5ML;EQ 62.5MG BASE/5ML A 065431 001 Nov 25, 2008 Dec CAHN

>A> AB 600MG/5ML;EQ 42.9MG BASE/5ML A 065420 001 Dec 02, 2013 Dec CAHN

>D> AB WOCKHARDT EU OPERATN 600MG/5ML;EQ 42.9MG BASE/5ML A 065420 001 Dec 02, 2013 Dec CAHN

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

TABLET;ORAL

DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

>D> AB MALLINCKRODT INC 1.25MG;1.25MG;1.25MG;1.25MG A 040440 001 Oct 07, 2003 Dec CAHN

>D> AB 1.875MG;1.875MG;1.875MG;1.875MG A 040440 002 Oct 07, 2003 Dec CAHN

>D> AB 2.5MG;2.5MG;2.5MG;2.5MG A 040440 003 Oct 07, 2003 Dec CAHN

>D> AB 3.125MG;3.125MG;3.125MG;3.125MG A 040440 004 Oct 07, 2003 Dec CAHN

>D> AB 3.75MG;3.75MG;3.75MG;3.75MG A 040440 005 Oct 07, 2003 Dec CAHN

>D> AB 5MG;5MG;5MG;5MG A 040440 006 Oct 07, 2003 Dec CAHN

>D> AB 7.5MG;7.5MG;7.5MG;7.5MG A 040440 007 Oct 07, 2003 Dec CAHN

>A> AB SPECGX LLC 1.25MG;1.25MG;1.25MG;1.25MG A 040440 001 Oct 07, 2003 Dec CAHN

>A> AB 1.875MG;1.875MG;1.875MG;1.875MG A 040440 002 Oct 07, 2003 Dec CAHN

>A> AB 2.5MG;2.5MG;2.5MG;2.5MG A 040440 003 Oct 07, 2003 Dec CAHN

>A> AB 3.125MG;3.125MG;3.125MG;3.125MG A 040440 004 Oct 07, 2003 Dec CAHN

>A> AB 3.75MG;3.75MG;3.75MG;3.75MG A 040440 005 Oct 07, 2003 Dec CAHN

>A> AB 5MG;5MG;5MG;5MG A 040440 006 Oct 07, 2003 Dec CAHN

>A> AB 7.5MG;7.5MG;7.5MG;7.5MG A 040440 007 Oct 07, 2003 Dec CAHN

>A> AB SUNRISE PHARM INC 1.25MG;1.25MG;1.25MG;1.25MG A 209799 001 Dec 28, 2017 Dec NEWA

>A> AB 1.875MG;1.875MG;1.875MG;1.875MG A 209799 002 Dec 28, 2017 Dec NEWA

>A> AB 2.5MG;2.5MG;2.5MG;2.5MG A 209799 003 Dec 28, 2017 Dec NEWA

>A> AB 3.125MG;3.125MG;3.125MG;3.125MG A 209799 004 Dec 28, 2017 Dec NEWA

>A> AB 3.75MG;3.75MG;3.75MG;3.75MG A 209799 005 Dec 28, 2017 Dec NEWA

>A> AB 5MG;5MG;5MG;5MG A 209799 006 Dec 28, 2017 Dec NEWA

>A> AB 7.5MG;7.5MG;7.5MG;7.5MG A 209799 007 Dec 28, 2017 Dec NEWA

>A> ANGIOTENSIN II

>A> SOLUTION;IV (INFUSION)

>A> GIAPREZA

>A> +! LA JOLLA PHARM CO 2.5MG/ML (2.5MG/ML) N 209360 001 Dec 21, 2017 Dec NEWA

>A> +! 5MG/2ML (2.5MG/ML) N 209360 002 Dec 21, 2017 Dec NEWA

ATROPINE; PRALIDOXIME CHLORIDE

INJECTABLE;INTRAMUSCULAR

ATNAA
>D> @ US ARMY 2.1MG/0.7ML;600MG/0.7ML N 021175 001 Jan 17, 2002 Dec CPOT
>A> @ 2.1MG/0.7ML;600MG/2ML N 021175 001 Jan 17, 2002 Dec CPOT

AZELASTINE HYDROCHLORIDE

SOLUTION/DROPS;OPHTHALMIC

AZELASTINE HYDROCHLORIDE

>D> AT SANDOZ INC 0.05% A 202305 001 May 31, 2012 Dec CHRS

>A> AT ! 0.05% A 202305 001 May 31, 2012 Dec CHRS

>D> OPTIVAR

>D> AT +! MYLAN SPECIALITY LP 0.05% N 021127 001 May 22, 2000 Dec DISC

>A> + @ 0.05% N 021127 001 May 22, 2000 Dec DISC

SPRAY, METERED;NASAL

AZELASTINE HYDROCHLORIDE

>A> AB AMNEAL PHARMS LLC EQ 0.1876MG BASE/SPRAY A 208199 001 Dec 15, 2017 Dec NEWA

BACLOFEN

TABLET;ORAL

BACLOFEN

>A> AB VINTAGE PHARMS 10MG A 077068 002 Aug 30, 2005 Dec CMS1

Page 3 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>A> BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM

>A> SOLUTION/DROPS;OPHTHALMIC
>A> ALTAFLUOR BENOX
>A> +! ALTAIRE PHARMS INC 0.4%;0.25% N 208582 001 Dec 14, 2017 Dec NEWA

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

GEL;TOPICAL
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
>A> AB TARO 5%;1.2% A 206218 001 Dec 15, 2017 Dec NEWA

BENZPHETAMINE HYDROCHLORIDE
TABLET;ORAL
BENZPHETAMINE HYDROCHLORIDE
>D> AA MALLINCKRODT INC 50MG A 040773 001 Apr 25, 2007 Dec CAHN
>A> AA SPECGX LLC 50MG A 040773 001 Apr 25, 2007 Dec CAHN

BIVALIRUDIN
>A> SOLUTION;IV (INFUSION)
>A> BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
>A> +! CELERITY PHARMS 250MG/50ML (5MG/ML) N 208374 001 Dec 21, 2017 Dec NEWA
>A> +! 500MG/100ML (5MG/ML) N 208374 002 Dec 21, 2017 Dec NEWA

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

TABLET;SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
>A> AB MALLINCKRODT INC EQ 2MG BASE;EQ 0.5MG BASE A 207000 001 Dec 13, 2017 Dec NEWA
>A> AB EQ 8MG BASE;EQ 2MG BASE A 207000 002 Dec 13, 2017 Dec NEWA
>A> AB SPECGX LLC EQ 2MG BASE;EQ 0.5MG BASE A 207000 001 Dec 13, 2017 Dec CAHN
>A> AB EQ 8MG BASE;EQ 2MG BASE A 207000 002 Dec 13, 2017 Dec CAHN

BUSULFAN
INJECTABLE;INJECTION
BUSULFAN
>A> AP AMNEAL PHARMS CO 6MG/ML A 209580 001 Dec 18, 2017 Dec NEWA

CAFFEINE CITRATE
SOLUTION;INTRAVENOUS
CAFFEINE CITRATE
>A> AP MICRO LABS EQ 30MG BASE/3ML (EQ 10MG A 207400 001 Dec 14, 2017 Dec NEWA
BASE/ML)

CALCIPOTRIENE
SOLUTION;TOPICAL
CALCIPOTRIENE
>A> AT NOVEL LABS INC 0.005% A 207163 001 Dec 26, 2017 Dec NEWA

CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

INJECTABLE;INJECTION
DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
>D> AP ICU MEDICAL INC 20MG/100ML;5GM/100ML;30MG/100ML N 017608 001 Aug 13, 1975 Dec CRLD
;600MG/100ML;310MG/100ML

>A> AP + 20MG/100ML;5GM/100ML;30MG/100ML N 017608 001 Aug 13, 1975 Dec CRLD

;600MG/100ML;310MG/100ML

CAPTOPRIL
TABLET;ORAL
CAPTOPRIL
>A> @ FOSUN PHARMA 12.5MG A 074363 001 Nov 09, 1995 Dec CAHN
>A> @ 25MG A 074363 002 Nov 09, 1995 Dec CAHN
>A> @ 50MG A 074363 003 Nov 09, 1995 Dec CAHN
>A> @ 100MG A 074363 004 Nov 09, 1995 Dec CAHN
>D> @ SANDOZ 12.5MG A 074363 001 Nov 09, 1995 Dec CAHN
>D> @ 25MG A 074363 002 Nov 09, 1995 Dec CAHN
>D> @ 50MG A 074363 003 Nov 09, 1995 Dec CAHN
>D> @ 100MG A 074363 004 Nov 09, 1995 Dec CAHN
>D> AB WOCKHARDT 12.5MG A 074532 001 Mar 28, 1997 Dec CAHN
>D> AB 25MG A 074532 002 Mar 28, 1997 Dec CAHN
>D> AB 50MG A 074532 003 Mar 28, 1997 Dec CAHN
>D> AB 100MG A 074532 004 Mar 28, 1997 Dec CAHN
>A> AB WOCKHARDT LTD 12.5MG A 074532 001 Mar 28, 1997 Dec CAHN

Page 4 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CAPTOPRIL

TABLET;ORAL

CAPTOPRIL

>A> AB
25MG
A 074532 002 Mar 28, 1997 Dec CAHN

>A> AB
50MG
A 074532 003 Mar 28, 1997 Dec CAHN

>A> AB
100MG
A 074532 004 Mar 28, 1997 Dec CAHN

CARBAMAZEPINE

SUSPENSION;ORAL

CARBAMAZEPINE

>D> AB WOCKHARDT
100MG/5ML
A 075714 001 Jun 05, 2002 Dec CAHN

>A> AB WOCKHARDT BIO AG
100MG/5ML
A 075714 001 Jun 05, 2002 Dec CAHN

CEFADROXIL/CEFADROXIL HEMIHYDRATE

CAPSULE;ORAL

CEFADROXIL

>D> AB SANDOZ
EQ 500MG BASE
A 062291 001 Jul 30, 1980 Dec DISC

>A> @
EQ 500MG BASE
A 062291 001 Jul 30, 1980 Dec DISC

CHLORHEXIDINE GLUCONATE

SOLUTION;DENTAL

CHLORHEXIDINE GLUCONATE

>D> AT WOCKHARDT
0.12%
A 075006 001 Mar 03, 2004 Dec CAHN

>A> AT WOCKHARDT BIO AG
0.12%
A 075006 001 Mar 03, 2004 Dec CAHN

CHLOROPROCAINE HYDROCHLORIDE

SOLUTION;INTRATHECAL

CLOROTEKAL

>A> + B BRAUN MEDICAL INC
50MG/5ML (10MG/ML)
N 208791 001 Sep 26, 2017 Dec CAHN

>D> + SINTETICA SA
50MG/5ML (10MG/ML)
N 208791 001 Sep 26, 2017 Dec CAHN

CIMETIDINE

TABLET;ORAL

CIMETIDINE

>A> @ FOSUN PHARMA
200MG
A 074100 001 Jan 31, 1995 Dec CAHN

>A> @
300MG
A 074100 002 Jan 31, 1995 Dec CAHN

>A> @
400MG
A 074100 003 Jan 31, 1995 Dec CAHN

>A> @
800MG
A 074100 004 Jan 31, 1995 Dec CAHN

>D> @ SANDOZ
200MG
A 074100 001 Jan 31, 1995 Dec CAHN

>D> @
300MG
A 074100 002 Jan 31, 1995 Dec CAHN

>D> @
400MG
A 074100 003 Jan 31, 1995 Dec CAHN

>D> @
800MG
A 074100 004 Jan 31, 1995 Dec CAHN

CIMETIDINE HYDROCHLORIDE

SOLUTION;ORAL

CIMETIDINE HYDROCHLORIDE

>D> AA WOCKHARDT
EQ 300MG BASE/5ML
A 074757 001 Oct 17, 1997 Dec CAHN

>A> AA WOCKHARDT BIO AG
EQ 300MG BASE/5ML
A 074757 001 Oct 17, 1997 Dec CAHN

CLOBETASOL PROPIONATE

SOLUTION;TOPICAL

CLOBETASOL PROPIONATE

>D> AT WOCKHARDT
0.05%
A 075205 001 Nov 13, 1998 Dec CAHN

>A> AT WOCKHARDT BIO AG
0.05%
A 075205 001 Nov 13, 1998 Dec CAHN

CLOMIPRAMINE HYDROCHLORIDE

CAPSULE;ORAL

ANAFRANIL

>D> AB +! MALLINCKRODT LLC
25MG
N 019906 001 Dec 29, 1989 Dec CAHN

>D> AB +
50MG
N 019906 002 Dec 29, 1989 Dec CAHN

>D> AB +
75MG
N 019906 003 Dec 29, 1989 Dec CAHN

>A> AB +! SPECGX LLC
25MG
N 019906 001 Dec 29, 1989 Dec CAHN

>A> AB +
50MG
N 019906 002 Dec 29, 1989 Dec CAHN

>A> AB +
75MG
N 019906 003 Dec 29, 1989 Dec CAHN

CLOMIPRAMINE HYDROCHLORIDE

>A> AB ZYDUS PHARMS USA INC
25MG
A 208961 001 Dec 27, 2017 Dec NEWA

>A> AB
50MG
A 208961 002 Dec 27, 2017 Dec NEWA

>A> AB
75MG
A 208961 003 Dec 27, 2017 Dec NEWA

Page 5 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>A> COCAINE HYDROCHLORIDE

>A> SOLUTION;NASAL

>A> GOPRELTO

>A> +! GENUS LIFESCIENCES 4%
N 209963 001 Dec 14, 2017 Dec NEWA

CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE

SYRUP;ORAL

PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE

>D> AA WOCKHARDT 10MG/5ML;6.25MG/5ML
A 088875 001 Dec 17, 1984 Dec CAHN

>A> AA WOCKHARDT BIO AG 10MG/5ML;6.25MG/5ML
A 088875 001 Dec 17, 1984 Dec CAHN

CROMOLYN SODIUM

SOLUTION;INHALATION

CROMOLYN SODIUM

>D> AN WOCKHARDT 10MG/ML
A 075346 001 Oct 25, 1999 Dec CAHN

>A> AN WOCKHARDT BIO AG 10MG/ML
A 075346 001 Oct 25, 1999 Dec CAHN

CYCLOSPORINE

SOLUTION;ORAL

CYCLOSPORINE

>D> AB2 WOCKHARDT 100MG/ML
A 065133 001 Sep 17, 2004 Dec CAHN

>A> AB2 WOCKHARDT BIO AG 100MG/ML
A 065133 001 Sep 17, 2004 Dec CAHN

CYPROHEPTADINE HYDROCHLORIDE

TABLET;ORAL

CYPROHEPTADINE HYDROCHLORIDE

>A> AA COREPHARMA 4MG
A 040537 001 Sep 30, 2003 Dec CAHN

>D> AA IMPAX LABS INC 4MG
A 040537 001 Sep 30, 2003 Dec CAHN

DESIPRAMINE HYDROCHLORIDE

TABLET;ORAL

DESIPRAMINE HYDROCHLORIDE

>A> AB COREPHARMA 10MG
A 205153 001 Oct 28, 2016 Dec CAHN

>A> AB 25MG
A 205153 002 Oct 28, 2016 Dec CAHN

>A> AB 50MG
A 205153 003 Oct 28, 2016 Dec CAHN

>A> AB 75MG
A 205153 004 Oct 28, 2016 Dec CAHN

>A> AB 100MG
A 205153 005 Oct 28, 2016 Dec CAHN

>A> AB 150MG
A 205153 006 Oct 28, 2016 Dec CAHN

>D> AB IMPAX LABS INC 10MG
A 205153 001 Oct 28, 2016 Dec CAHN

>D> AB 25MG
A 205153 002 Oct 28, 2016 Dec CAHN

>D> AB 50MG
A 205153 003 Oct 28, 2016 Dec CAHN

>D> AB 75MG
A 205153 004 Oct 28, 2016 Dec CAHN

>D> AB 100MG
A 205153 005 Oct 28, 2016 Dec CAHN

>D> AB 150MG
A 205153 006 Oct 28, 2016 Dec CAHN

>A> AB INGENUS PHARMS LLC 10MG
A 204963 001 Dec 26, 2017 Dec NEWA

>A> AB 25MG
A 204963 002 Dec 26, 2017 Dec NEWA

>A> AB 50MG
A 204963 003 Dec 26, 2017 Dec NEWA

>A> AB 75MG
A 204963 004 Dec 26, 2017 Dec NEWA

>A> AB 100MG
A 204963 005 Dec 26, 2017 Dec NEWA

>A> AB 150MG
A 204963 006 Dec 26, 2017 Dec NEWA

DEXAMETHASONE

ELIXIR;ORAL

DEXAMETHASONE

>A> AA WOCKHARDT BIO AG 0.5MG/5ML
A 088254 001 Jul 27, 1983 Dec CAHN

>D> AA WOCKHARDT EU OPERATN 0.5MG/5ML
A 088254 001 Jul 27, 1983 Dec CAHN

DEXCHLORPHENIRAMINE MALEATE

SYRUP;ORAL

DEXCHLORPHENIRAMINE MALEATE

>D> ! WOCKHARDT 2MG/5ML
A 088251 001 Mar 23, 1984 Dec CAHN

>A> ! WOCKHARDT BIO AG 2MG/5ML
A 088251 001 Mar 23, 1984 Dec CAHN

DEXTROAMPHETAMINE SULFATE

CAPSULE, EXTENDED RELEASE;ORAL

DEXTROAMPHETAMINE SULFATE

>D> AB MALLINCKRODT 5MG
A 076353 001 May 06, 2003 Dec CAHN

>D> AB 10MG
A 076353 002 May 06, 2003 Dec CAHN

>D> AB 15MG
A 076353 003 May 06, 2003 Dec CAHN

>A> AB SPECGX LLC 5MG
A 076353 001 May 06, 2003 Dec CAHN

Page 6 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DEXTROAMPHETAMINE SULFATE

CAPSULE, EXTENDED RELEASE;ORAL

DEXTROAMPHETAMINE SULFATE

>A> AB 10MG A 076353 002 May 06, 2003 Dec CAHN

>A> AB 15MG A 076353 003 May 06, 2003 Dec CAHN

TABLET;ORAL

DEXTROAMPHETAMINE SULFATE

>D> AA MALLINCKRODT 5MG A 040436 001 Jan 29, 2002 Dec CAHN

>D> AA 10MG A 040436 002 Jan 29, 2002 Dec CAHN

>A> AA SPECGX LLC 5MG A 040436 001 Jan 29, 2002 Dec CAHN

>A> AA 10MG A 040436 002 Jan 29, 2002 Dec CAHN

DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE

SYRUP;ORAL

PROMETHAZINE W/ DEXTROMETHORPHAN

>D> AA WOCKHARDT 15MG/5ML;6.25MG/5ML A 088864 001 Jan 04, 1985 Dec CAHN

>A> AA WOCKHARDT BIO AG 15MG/5ML;6.25MG/5ML A 088864 001 Jan 04, 1985 Dec CAHN

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

INJECTABLE;INJECTION

POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER

>D> ICU MEDICAL INC 5GM/100ML;74.5MG/100ML;225MG/10 N 018365 002 Jul 05, 1983 Dec CRLD

0ML

>A> + 5GM/100ML;74.5MG/100ML;225MG/10 N 018365 002 Jul 05, 1983 Dec CRLD

0ML

>D> 5GM/100ML;149MG/100ML;225MG/100 N 018365 006 Mar 28, 1988 Dec CRLD

ML

>A> + 5GM/100ML;149MG/100ML;225MG/100 N 018365 006 Mar 28, 1988 Dec CRLD

ML

POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER

>D> ICU MEDICAL INC 5GM/100ML;149MG/100ML;225MG/100 N 018365 001 May 29, 1980 Dec CRLD

ML

>A> + 5GM/100ML;149MG/100ML;225MG/100 N 018365 001 May 29, 1980 Dec CRLD

ML

>D> 5GM/100ML;298MG/100ML;225MG/100 N 018365 009 Mar 28, 1988 Dec CRLD

ML

>A> + 5GM/100ML;298MG/100ML;225MG/100 N 018365 009 Mar 28, 1988 Dec CRLD

ML

DOXAZOSIN MESYLATE

TABLET;ORAL

DOXAZOSIN MESYLATE

>A> @ FOSUN PHARMA EQ 1MG BASE A 075646 001 Oct 18, 2000 Dec CAHN

>A> @ EQ 2MG BASE A 075646 002 Oct 18, 2000 Dec CAHN

>A> @ EQ 4MG BASE A 075646 003 Oct 18, 2000 Dec CAHN

>A> @ EQ 8MG BASE A 075646 004 Oct 18, 2000 Dec CAHN

>D> @ SANDOZ EQ 1MG BASE A 075646 001 Oct 18, 2000 Dec CAHN

>D> @ EQ 2MG BASE A 075646 002 Oct 18, 2000 Dec CAHN

>D> @ EQ 4MG BASE A 075646 003 Oct 18, 2000 Dec CAHN

>D> @ EQ 8MG BASE A 075646 004 Oct 18, 2000 Dec CAHN

DOXEPIN HYDROCHLORIDE

CONCENTRATE;ORAL

DOXEPIN HYDROCHLORIDE

>D> AA WOCKHARDT EQ 10MG BASE/ML A 071918 001 Jul 20, 1988 Dec CAHN

>A> AA WOCKHARDT BIO AG EQ 10MG BASE/ML A 071918 001 Jul 20, 1988 Dec CAHN

DOXYCYCLINE HYCLATE

TABLET, DELAYED RELEASE;ORAL

DORYX MPC

>D> + MAYNE PHARMA EQ 60MG BASE N 050795 007 May 20, 2016 Dec DISC

>A> + @ EQ 60MG BASE N 050795 007 May 20, 2016 Dec DISC

DROPERIDOL

INJECTABLE;INJECTION

DROPERIDOL

>A> AP EUROHLTH INTL SARL 2.5MG/ML A 208197 001 Dec 14, 2017 Dec NEWA

Page 7 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DROSPIRENONE; ETHINYL ESTRADIOL

TABLET;ORAL

DROSPIRENONE AND ETHINYL ESTRADIOL

>A> AB CYNDEA PHARMA 3MG;0.02MG A 209423 001 Dec 22, 2017 Dec NEWA

EFAVIRENZ

CAPSULE;ORAL

EFAVIRENZ

>A> AB AUROBINDO PHARMA LTD 50MG A 078064 001 Dec 15, 2017 Dec NEWA

>A> 100MG A 078064 002 Dec 15, 2017 Dec NEWA

>A> AB 200MG A 078064 003 Dec 15, 2017 Dec NEWA

SUSTIVA

>D> + BRISTOL MYERS SQUIBB 50MG N 020972 001 Sep 17, 1998 Dec CFTG

>A> AB + 50MG N 020972 001 Sep 17, 1998 Dec CFTG

>D> +! 200MG N 020972 003 Sep 17, 1998 Dec CFTG

>A> AB +! 200MG N 020972 003 Sep 17, 1998 Dec CFTG

ENALAPRIL MALEATE

TABLET;ORAL

ENALAPRIL MALEATE

>A> AB WOCKHARDT LTD 2.5MG A 075483 001 Aug 22, 2000 Dec CAHN

>A> AB 5MG A 075483 002 Aug 22, 2000 Dec CAHN

>A> AB 10MG A 075483 003 Aug 22, 2000 Dec CAHN

>A> AB 20MG A 075483 004 Aug 22, 2000 Dec CAHN

>D> AB WOCKHARDT USA 2.5MG A 075483 001 Aug 22, 2000 Dec CAHN

>D> AB 5MG A 075483 002 Aug 22, 2000 Dec CAHN

>D> AB 10MG A 075483 003 Aug 22, 2000 Dec CAHN

>D> AB 20MG A 075483 004 Aug 22, 2000 Dec CAHN

EPINEPHRINE

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

SYMJEPI

>D> +! ADAMIS PHARMS CORP 0.3MG/ML (0.3MG/ML) N 207534 001 Jun 15, 2017 Dec CPOT

>A> +! 0.3MG/0.3ML (0.3MG/0.3ML) N 207534 001 Jun 15, 2017 Dec CPOT

>A> ERTUGLIFLOZIN

>A> TABLET;ORAL

>A> STEGLATRO

>A> + MERCK SHARP DOHME 5MG N 209803 001 Dec 19, 2017 Dec NEWA

>A> +! 15MG N 209803 002 Dec 19, 2017 Dec NEWA

>A> ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

>A> TABLET;ORAL

>A> SEGLUROMET

>A> + MERCK SHARP DOHME 2.5MG;500MG N 209806 001 Dec 19, 2017 Dec NEWA

>A> + 2.5MG;1GM N 209806 002 Dec 19, 2017 Dec NEWA

>A> + 7.5MG;500MG N 209806 003 Dec 19, 2017 Dec NEWA

>A> +! 7.5MG;1GM N 209806 004 Dec 19, 2017 Dec NEWA

>A> ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

>A> TABLET;ORAL

>A> STELUJAN

>A> + MERCK SHARP DOHME 5MG;EQ 100MG BASE N 209805 001 Dec 19, 2017 Dec NEWA

>A> +! 15MG;EQ 100MG BASE N 209805 002 Dec 19, 2017 Dec NEWA

ERYTHROMYCIN

SOLUTION;TOPICAL

ERYTHROMYCIN

>D> AT WOCKHARDT 2% A 062825 001 Oct 23, 1987 Dec CAHN

>A> AT WOCKHARDT BIO AG 2% A 062825 001 Oct 23, 1987 Dec CAHN

ESOMEPRAZOLE SODIUM

INJECTABLE;INTRAVENOUS

ESOMEPRAZOLE SODIUM

>D> AP ! AUROBINDO PHARMA LTD EQ 20MG BASE/VIAL A 204657 001 Aug 10, 2016 Dec DISC

>A> @ EQ 20MG BASE/VIAL A 204657 001 Aug 10, 2016 Dec DISC

>D> AP EQ 40MG BASE/VIAL A 204657 002 Aug 10, 2016 Dec CHRS

>A> AP ! EQ 40MG BASE/VIAL A 204657 002 Aug 10, 2016 Dec CHRS

>D> AP MYLAN LABS LTD EQ 20MG BASE/VIAL A 202686 001 May 17, 2017 Dec DISC

>A> @ EQ 20MG BASE/VIAL A 202686 001 May 17, 2017 Dec DISC

Page 8 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ESOMEPRAZOLE SODIUM

INJECTABLE;INTRAVENOUS

ESOMEPRAZOLE SODIUM

>D> AP SUN PHARMA GLOBAL EQ 20MG BASE/VIAL
A 200882 001 Mar 18, 2013 Dec DISC

>A> @ EQ 20MG BASE/VIAL
A 200882 001 Mar 18, 2013 Dec DISC

ESOMEPRAZOLE STRONTIUM

CAPSULE, DELAYED RELEASE;ORAL

ESOMEPRAZOLE STRONTIUM

>D> + R2 PHARMA LLC 24.65MG
N 202342 001 Aug 06, 2013 Dec DISC

>A> + @ 24.65MG
N 202342 001 Aug 06, 2013 Dec DISC

ESTRADIOL

CREAM;VAGINAL

ESTRACE

>D> ! ALLERGAN SALES LLC 0.01%
A 086069 001 Jan 31, 1984 Dec CFTG

>A> AB ! 0.01%
A 086069 001 Jan 31, 1984 Dec CFTG

>A> ESTRADIOL

>A> AB MYLAN PHARMS INC 0.01%
A 208788 001 Dec 29, 2017 Dec NEWA

ESTROPIPATE

TABLET;ORAL

ESTROPIPATE

>D> AB MYLAN 0.75MG
A 040359 001 Aug 26, 1999 Dec CTEC

>A> 0.75MG
A 040359 001 Aug 26, 1999 Dec CTEC

>D> AB 1.5MG
A 040359 002 Aug 26, 1999 Dec CTEC

>A> 1.5MG
A 040359 002 Aug 26, 1999 Dec CTEC

>D> AB WATSON LABS 0.75MG
A 081213 001 Sep 23, 1993 Dec DISC

>A> @ 0.75MG
A 081213 001 Sep 23, 1993 Dec DISC

>D> AB 1.5MG
A 081214 001 Sep 23, 1993 Dec DISC

>A> @ 1.5MG
A 081214 001 Sep 23, 1993 Dec DISC

>D> ! WATSON LABS TEVA 3MG
A 081215 001 Sep 23, 1993 Dec DISC

>A> @ 3MG
A 081215 001 Sep 23, 1993 Dec DISC

ETHINYL ESTRADIOL; ETONOGESTREL

RING;VAGINAL

NUVARING

>A> +! ORGANON SUB MERCK 0.015MG/24HR;0.12MG/24HR
N 021187 001 Oct 03, 2001 Dec CAHN

>D> +! ORGANON USA INC 0.015MG/24HR;0.12MG/24HR
N 021187 001 Oct 03, 2001 Dec CAHN

ETHINYL ESTRADIOL; LEVONORGESTREL

TABLET;ORAL

>A> JAIMIESS

>A> AB LABS LEON FARMA 0.03MG,0.01MG;0.15MG,N/A
A 203770 001 Dec 27, 2017 Dec NEWA

LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL

>A> AB LABS LEON FARMA 0.02MG,0.01MG;0.1MG,N/A
A 205131 001 Dec 14, 2017 Dec NEWA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

TABLET, CHEWABLE;ORAL

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

>A> AB GLENMARK PHARMS LTD 0.02MG;1MG
A 210369 001 Dec 26, 2017 Dec NEWA

EZETIMIBE

TABLET;ORAL

EZETIMIBE

>A> AB ALKEM LABS LTD 10MG
A 209234 001 Dec 21, 2017 Dec NEWA

EZETIMIBE; SIMVASTATIN

TABLET;ORAL

EZETIMIBE AND SIMVASTATIN

>A> AB ALKEM LABS LTD 10MG;10MG
A 209222 001 Dec 22, 2017 Dec NEWA

>A> AB 10MG;20MG
A 209222 002 Dec 22, 2017 Dec NEWA

>A> AB 10MG;40MG
A 209222 003 Dec 22, 2017 Dec NEWA

>A> AB 10MG;80MG
A 209222 004 Dec 22, 2017 Dec NEWA

FAMOTIDINE

TABLET;ORAL

FAMOTIDINE

>D> AB WOCKHARDT 20MG
A 075786 001 Apr 16, 2001 Dec CAHN

>D> AB 40MG
A 075786 002 Apr 16, 2001 Dec CAHN

>A> AB WOCKHARDT LTD 20MG
A 075786 001 Apr 16, 2001 Dec CAHN

Page 9 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FAMOTIDINE

TABLET;ORAL

FAMOTIDINE

>A> AB
40MG
A 075786 002 Apr 16, 2001 Dec CAHN

FENOFIBRATE

TABLET;ORAL

FENOFIBRATE

>A> AB CNTY LINE PHARMS
54MG
A 207803 001 Dec 19, 2017 Dec NEWA

>A> AB
160MG
A 207803 002 Dec 19, 2017 Dec NEWA

FENTANYL

FILM, EXTENDED RELEASE;TRANSDERMAL

FENTANYL-100

>D> AB MALLINCKRODT INC
100MCG/HR
A 077154 004 Feb 09, 2011 Dec CAHN

>A> AB SPECGX LLC
100MCG/HR
A 077154 004 Feb 09, 2011 Dec CAHN

FENTANYL-12

>D> AB MALLINCKRODT INC
12.5MCG/HR
A 077154 005 Jun 11, 2015 Dec CAHN

>A> AB SPECGX LLC
12.5MCG/HR
A 077154 005 Jun 11, 2015 Dec CAHN

FENTANYL-25

>D> AB MALLINCKRODT INC
25MCG/HR
A 077154 001 Feb 09, 2011 Dec CAHN

>A> AB SPECGX LLC
25MCG/HR
A 077154 001 Feb 09, 2011 Dec CAHN

FENTANYL-50

>D> AB MALLINCKRODT INC
50MCG/HR
A 077154 002 Feb 09, 2011 Dec CAHN

>A> AB SPECGX LLC
50MCG/HR
A 077154 002 Feb 09, 2011 Dec CAHN

FENTANYL-75

>D> AB MALLINCKRODT INC
75MCG/HR
A 077154 003 Feb 09, 2011 Dec CAHN

>A> AB SPECGX LLC
75MCG/HR
A 077154 003 Feb 09, 2011 Dec CAHN

FENTANYL CITRATE

TROCHE/LOZENGE;TRANSMUCOSAL

FENTANYL CITRATE

>D> AB MALLINCKRODT
EQ 0.2MG BASE
A 078907 001 Oct 30, 2009 Dec CAHN

>D> AB
EQ 0.4MG BASE
A 078907 002 Oct 30, 2009 Dec CAHN

>D> AB
EQ 0.6MG BASE
A 078907 003 Oct 30, 2009 Dec CAHN

>D> AB
EQ 0.8MG BASE
A 078907 004 Oct 30, 2009 Dec CAHN

>D> AB
EQ 1.2MG BASE
A 078907 005 Oct 30, 2009 Dec CAHN

>D> AB
EQ 1.6MG BASE
A 078907 006 Oct 30, 2009 Dec CAHN

>A> AB SPECGX LLC
EQ 0.2MG BASE
A 078907 001 Oct 30, 2009 Dec CAHN

>A> AB
EQ 0.4MG BASE
A 078907 002 Oct 30, 2009 Dec CAHN

>A> AB
EQ 0.6MG BASE
A 078907 003 Oct 30, 2009 Dec CAHN

>A> AB
EQ 0.8MG BASE
A 078907 004 Oct 30, 2009 Dec CAHN

>A> AB
EQ 1.2MG BASE
A 078907 005 Oct 30, 2009 Dec CAHN

>A> AB
EQ 1.6MG BASE
A 078907 006 Oct 30, 2009 Dec CAHN

FLUOCINOLONE ACETONIDE

SOLUTION;TOPICAL

FLUOCINOLONE ACETONIDE

>A> AT GLASSHOUSE PHARMS
0.01%
A 209596 001 Dec 26, 2017 Dec NEWA

FLUOROURACIL

INJECTABLE;INJECTION

FLUOROURACIL

>A> AP GLAND PHARMA LTD
2.5GM/50ML (50MG/ML)
A 210124 001 Dec 26, 2017 Dec NEWA

>A> AP
5GM/100ML (50MG/ML)
A 210124 002 Dec 26, 2017 Dec NEWA

FLUOXETINE HYDROCHLORIDE

CAPSULE;ORAL

FLUOXETINE HYDROCHLORIDE

>D> AB1 MALLINCKRODT
EQ 10MG BASE
A 075658 001 Jan 29, 2002 Dec CAHN

>D> AB1
EQ 20MG BASE
A 075658 002 Jan 29, 2002 Dec CAHN

>A> AB1 SPECGX LLC
EQ 10MG BASE
A 075658 001 Jan 29, 2002 Dec CAHN

>A> AB1
EQ 20MG BASE
A 075658 002 Jan 29, 2002 Dec CAHN

SOLUTION;ORAL

FLUOXETINE HYDROCHLORIDE

>D> AA MALLINCKRODT
EQ 20MG BASE/5ML
A 075920 001 Jan 29, 2002 Dec CAHN

>A> AA SPECGX LLC
EQ 20MG BASE/5ML
A 075920 001 Jan 29, 2002 Dec CAHN

>D> AA WOCKHARDT
EQ 20MG BASE/5ML
A 075514 001 Aug 29, 2002 Dec CAHN

>A> AA WOCKHARDT BIO AG
EQ 20MG BASE/5ML
A 075514 001 Aug 29, 2002 Dec CAHN

Page 10 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FLUPHENAZINE HYDROCHLORIDE

TABLET;ORAL

PROLIXIN

>D> @ APOTHECON
1MG
N 011751 004 Sep 30, 1959 Dec CRLD

>A> + @
1MG
N 011751 004 Sep 30, 1959 Dec CRLD

>D> @
2.5MG
N 011751 001 Sep 15, 1959 Dec CRLD

>A> + @
2.5MG
N 011751 001 Sep 15, 1959 Dec CRLD

>D> @
5MG
N 011751 003 Sep 15, 1959 Dec CRLD

>A> + @
5MG
N 011751 003 Sep 15, 1959 Dec CRLD

>D> @
10MG
N 011751 002 Sep 15, 1959 Dec CRLD

>A> + @
10MG
N 011751 002 Sep 15, 1959 Dec CRLD

FLUTAMIDE

CAPSULE;ORAL

FLUTAMIDE

>A> @ FOSUN PHARMA
125MG
A 075818 001 Sep 18, 2001 Dec CAHN

>D> @ SANDOZ
125MG
A 075818 001 Sep 18, 2001 Dec CAHN

FLUTICASONE PROPIONATE

SPRAY, METERED;NASAL

FLUTICASONE PROPIONATE

>D> AB WOCKHARDT
0.05MG/SPRAY
A 078492 001 Jan 09, 2012 Dec CAHN

>A> AB WOCKHARDT BIO AG
0.05MG/SPRAY
A 078492 001 Jan 09, 2012 Dec CAHN

FONDAPARINUX SODIUM

INJECTABLE;SUBCUTANEOUS

FONDAPARINUX SODIUM

>A> AP AUROBINDO PHARMA LTD
2.5MG/0.5ML
A 206918 001 Dec 26, 2017 Dec NEWA

>A> AP
5MG/0.4ML
A 206918 002 Dec 26, 2017 Dec NEWA

>A> AP
7.5MG/0.6ML
A 206918 003 Dec 26, 2017 Dec NEWA

>A> AP
10MG/0.8ML
A 206918 004 Dec 26, 2017 Dec NEWA

FUROSEMIDE

SOLUTION;ORAL

FUROSEMIDE

>D> AA WOCKHARDT
10MG/ML
A 070655 001 Oct 02, 1987 Dec CAHN

>A> AA WOCKHARDT BIO AG
10MG/ML
A 070655 001 Oct 02, 1987 Dec CAHN

GEMFIBROZIL

TABLET;ORAL

GEMFIBROZIL

>A> @ FOSUN PHARMA
600MG
A 074615 001 Sep 29, 1995 Dec CAHN

>D> @ SANDOZ
600MG
A 074615 001 Sep 29, 1995 Dec CAHN

GENTAMICIN SULFATE

SOLUTION/DROPS;OPHTHALMIC

GENTAMICIN SULFATE

>D> @ BAUSCH AND LOMB
EQ 0.3% BASE
A 064048 001 May 11, 1994 Dec CMFD

>A> AT
EQ 0.3% BASE
A 064048 001 May 11, 1994 Dec CMFD

GLYBURIDE

TABLET;ORAL

GLYBURIDE (MICRONIZED)

>A> @ FOSUN PHARMA

1.5MG
A 075174 001 Jun 22, 1998 Dec CAHN

>A> @
3MG
A 075174 002 Jun 22, 1998 Dec CAHN

>D> @ SANDOZ
1.5MG
A 075174 001 Jun 22, 1998 Dec CAHN

>D> @
3MG
A 075174 002 Jun 22, 1998 Dec CAHN

GLYCOPYRROLATE

INJECTABLE;INJECTION

GLYCOPYRROLATE

>D> AA FRESENIUS KABI USA
0.2MG/ML
A 209328 001 Oct 27, 2017 Dec CTEC

>A> AP
0.2MG/ML
A 209328 001 Oct 27, 2017 Dec CTEC

SOLUTION;INHALATION

>A> LONHALA MAGNAIR KIT

>A> +! SUNOVION RESP
25MCG/ML
N 208437 001 Dec 05, 2017 Dec NEWA

Page 11 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

GRANISETRON HYDROCHLORIDE

INJECTABLE;INJECTION

GRANISETRON HYDROCHLORIDE

>A> AP MYLAN ASI EQ 4MG BASE/4ML (EQ 1MG A 091137 002 Apr 09, 2010 Dec CAHN

BASE/ML)

>D> AP SAGENT AGILA EQ 4MG BASE/4ML (EQ 1MG A 091137 002 Apr 09, 2010 Dec CAHN

BASE/ML)

GRISEOFULVIN, ULTRAMICROSIZE

TABLET;ORAL

GRISEOFULVIN, ULTRAMICROSIZE

>A> AB COREPHARMA 125MG A 204371 001 Jan 09, 2014 Dec CAHN

>A> AB 250MG A 204371 002 Jan 09, 2014 Dec CAHN

>D> AB IMPAX LABS INC 125MG A 204371 001 Jan 09, 2014 Dec CAHN

>D> AB 250MG A 204371 002 Jan 09, 2014 Dec CAHN

HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE

SYRUP;ORAL

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

>D> AA WOCKHARDT 1.5MG/5ML;5MG/5ML A 088008 001 Mar 03, 1983 Dec CAHN

>A> AA WOCKHARDT BIO AG 1.5MG/5ML;5MG/5ML A 088008 001 Mar 03, 1983 Dec CAHN

HYDROCHLOROTHIAZIDE

TABLET;ORAL

HYDROCHLOROTHIAZIDE

>A> @ FOSUN PHARMA 25MG A 087565 001 Mar 09, 1982 Dec CAHN

>A> @ 50MG A 084912 001 Dec 17, 1976 Dec CAHN

>A> AB LEADING PHARMA LLC 12.5MG A 040702 003 May 10, 2017 Dec NEWA

>D> @ SANDOZ 25MG A 087565 001 Mar 09, 1982 Dec CAHN

>D> @ 50MG A 084912 001 Dec 17, 1976 Dec CAHN

HYDROCHLOROTHIAZIDE; METHYLDOPA

TABLET;ORAL

METHYLDOPA AND HYDROCHLOROTHIAZIDE

>A> @ FOSUN PHARMA 15MG;250MG A 070182 001 Jan 15, 1986 Dec CAHN

>A> @ 25MG;250MG A 070183 001 Jan 15, 1986 Dec CAHN

>A> @ 30MG;500MG A 070543 001 Jan 15, 1986 Dec CAHN

>D> @ SANDOZ 15MG;250MG A 070182 001 Jan 15, 1986 Dec CAHN

>D> @ 25MG;250MG A 070183 001 Jan 15, 1986 Dec CAHN

>D> @ 30MG;500MG A 070543 001 Jan 15, 1986 Dec CAHN

HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

TABLET;ORAL

PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

>A> @ FOSUN PHARMA 25MG;40MG A 071060 001 Aug 26, 1987 Dec CAHN

>A> @ 25MG;80MG A 071061 001 Aug 26, 1987 Dec CAHN

>D> @ SANDOZ 25MG;40MG A 071060 001 Aug 26, 1987 Dec CAHN

>D> @ 25MG;80MG A 071061 001 Aug 26, 1987 Dec CAHN

HYDROCHLOROTHIAZIDE; SPIRONOLACTONE

TABLET;ORAL

SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE

>A> @ FOSUN PHARMA 25MG;25MG A 086881 001 Jul 10, 1980 Dec CAHN

>D> @ SANDOZ 25MG;25MG A 086881 001 Jul 10, 1980 Dec CAHN

HYDROCODONE BITARTRATE

CAPSULE, EXTENDED RELEASE;ORAL

ZOHYDRO ER

>D> +! PERNIX IRELAND PAIN 10MG N 202880 001 Oct 25, 2013 Dec CAHN

>A> +! 10MG N 202880 001 Oct 25, 2013 Dec CAHN

>D> + 15MG N 202880 002 Oct 25, 2013 Dec CAHN

>A> + 15MG N 202880 002 Oct 25, 2013 Dec CAHN

>D> + 20MG N 202880 003 Oct 25, 2013 Dec CAHN

>A> + 20MG N 202880 003 Oct 25, 2013 Dec CAHN

>D> + 30MG N 202880 004 Oct 25, 2013 Dec CAHN

>A> + 30MG N 202880 004 Oct 25, 2013 Dec CAHN

>D> + 40MG N 202880 005 Oct 25, 2013 Dec CAHN

>A> + 40MG N 202880 005 Oct 25, 2013 Dec CAHN

>D> + 50MG N 202880 006 Oct 25, 2013 Dec CAHN

>A> + 50MG N 202880 006 Oct 25, 2013 Dec CAHN

Page 12 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

SUSPENSION/DROPS;OTIC

>A> CASPORYN HC

>A> AT +! CASPER PHARMA LLC 1%;EQ 3.5MG BASE/ML;10,000 N 060613 001 May 25, 1975 Dec CTNA

UNITS/ML

>D> CORTISPORIN

>D> AT +! CASPER PHARMA LLC 1%;EQ 3.5MG BASE/ML;10,000 N 060613 001 May 25, 1975 Dec CTNA

UNITS/ML

>A> HYDROGEN PEROXIDE

>A> SOLUTION;TOPICAL

>A> ESKATA

>A> +! ACLARIS THERAPS INC 40% N 209305 001 Dec 14, 2017 Dec NEWA

HYDROMORPHONE HYDROCHLORIDE

TABLET, EXTENDED RELEASE;ORAL

EXALGO

>D> AB + MALLINCKRODT INC 8MG N 021217 001 Mar 01, 2010 Dec CAHN

>D> AB + 12MG N 021217 002 Mar 01, 2010 Dec CAHN

>D> AB + 16MG N 021217 003 Mar 01, 2010 Dec CAHN

>D> AB +! 32MG N 021217 004 Aug 24, 2012 Dec CAHN

>A> AB + SPECGX LLC 8MG N 021217 001 Mar 01, 2010 Dec CAHN

>A> AB + 12MG N 021217 002 Mar 01, 2010 Dec CAHN

>A> AB + 16MG N 021217 003 Mar 01, 2010 Dec CAHN

>A> AB +! 32MG N 021217 004 Aug 24, 2012 Dec CAHN

TABLET;ORAL

HYDROMORPHONE HYDROCHLORIDE

>D> AB MALLINCKRODT 2MG A 076855 002 Sep 19, 2007 Dec CAHN

>D> AB 4MG A 076855 003 Sep 19, 2007 Dec CAHN

>D> AB 8MG A 076855 001 Dec 23, 2004 Dec CAHN

>A> AB SPECGX LLC 2MG A 076855 002 Sep 19, 2007 Dec CAHN

>A> AB 4MG A 076855 003 Sep 19, 2007 Dec CAHN

>A> AB 8MG A 076855 001 Dec 23, 2004 Dec CAHN

HYDROXYUREA

>A> TABLET;ORAL

>A> SIKLOS

>A> + ADDMEDICA SAS 100MG N 208843 001 Dec 21, 2017 Dec NEWA

>A> + 1GM N 208843 002 Dec 21, 2017 Dec NEWA

HYDROXYZINE HYDROCHLORIDE

SYRUP;ORAL

HYDROXYZINE HYDROCHLORIDE

>D> AA ! WOCKHARDT 10MG/5ML A 087294 001 Apr 12, 1982 Dec CAHN

>A> AA ! WOCKHARDT BIO AG 10MG/5ML A 087294 001 Apr 12, 1982 Dec CAHN

IBRUTINIB

CAPSULE;ORAL

IMBRUVICA

>A> + PHARMACYCLICS INC 70MG N 205552 002 Dec 20, 2017 Dec NEWA

IMIPRAMINE HYDROCHLORIDE

TABLET;ORAL

IMIPRAMINE HYDROCHLORIDE

>D> AB MALLINCKRODT INC 10MG A 087846 002 May 22, 1984 Dec CAHN

>D> AB 25MG A 087846 003 May 22, 1984 Dec CAHN

>A> AB SPECGX LLC 10MG A 087846 002 May 22, 1984 Dec CAHN

>A> AB 25MG A 087846 003 May 22, 1984 Dec CAHN

TOFRANIL

>D> AB ! MALLINCKRODT INC 50MG A 087846 001 May 22, 1984 Dec CAHN

>A> AB ! SPECGX LLC 50MG A 087846 001 May 22, 1984 Dec CAHN

IMIPRAMINE PAMOATE

CAPSULE;ORAL

TOFRANIL-PM

>D> + @ MALLINCKRODT INC EQ 75MG HCL N 017090 001 Mar 15, 1973 Dec CAHN

>D> + @ EQ 100MG HCL N 017090 004 Mar 08, 1974 Dec CAHN

>D> + @ EQ 125MG HCL N 017090 003 Mar 08, 1974 Dec CAHN

>D> + @ EQ 150MG HCL N 017090 002 Mar 15, 1973 Dec CAHN

>A> + @ SPECGX LLC EQ 75MG HCL N 017090 001 Mar 15, 1973 Dec CAHN

>A> + @ EQ 100MG HCL N 017090 004 Mar 08, 1974 Dec CAHN

Page 13 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

IMIPRAMINE PAMOATE

CAPSULE;ORAL

TOFRANIL-PM

>A> + @ EQ 125MG HCL N 017090 003 Mar 08, 1974 Dec CAHN

>A> + @ EQ 150MG HCL N 017090 002 Mar 15, 1973 Dec CAHN

INDAPAMIDE

TABLET;ORAL

INDAPAMIDE

>A> @ FOSUN PHARMA 1.25MG A 074594 001 May 23, 1996 Dec CAHN

>A> @ 2.5MG A 074594 002 May 23, 1996 Dec CAHN

>D> @ SANDOZ 1.25MG A 074594 001 May 23, 1996 Dec CAHN

>D> @ 2.5MG A 074594 002 May 23, 1996 Dec CAHN

>A> INSULIN ASPART

>A> SOLUTION;IV (INFUSION), SUBCUTANEOUS

>A> FIASP

>A> +! NOVO NORDISK INC 1000 UNITS/10ML (100 UNITS/ML) N 208751 001 Sep 29, 2017 Dec CAIN

>A> SOLUTION;SUBCUTANEOUS

>A> FIASP FLEXTOUCH

>A> +! NOVO NORDISK INC 300 UNITS/3ML (100 UNITS/ML) N 208751 002 Sep 29, 2017 Dec CAIN

>D> INSULIN ASPART RECOMBINANT

>D> SOLUTION;IV (INFUSION), SUBCUTANEOUS

>D> FIASP

>D> +! NOVO NORDISK INC 1000 UNITS/10ML (100 UNITS/ML) N 208751 001 Sep 29, 2017 Dec CAIN

>D> SOLUTION;SUBCUTANEOUS

>D> FIASP FLEXTOUCH

>D> +! NOVO NORDISK INC 300 UNITS/3ML (100 UNITS/ML) N 208751 002 Sep 29, 2017 Dec CAIN

INSULIN LISPRO

SOLUTION;IV (INFUSION), SUBCUTANEOUS

>A> ADMELOG

>A> + SANOFI-AVENTIS US 1000 UNITS/10ML (100 UNITS/ML) N 209196 001 Dec 11, 2017 Dec NEWA

>A> ADMELOG SOLOSTAR

>A> + SANOFI-AVENTIS US 300 UNITS/3ML (100 UNITS/ML) N 209196 002 Dec 11, 2017 Dec NEWA

IRBESARTAN

TABLET;ORAL

IRBESARTAN

>D> AB MYLAN PHARMS INC 75MG A 200461 001 Sep 27, 2012 Dec DISC

>A> @ 75MG A 200461 001 Sep 27, 2012 Dec DISC

>D> AB 150MG A 200461 002 Sep 27, 2012 Dec DISC

>A> @ 150MG A 200461 002 Sep 27, 2012 Dec DISC

>D> AB 300MG A 200461 003 Sep 27, 2012 Dec DISC

>A> @ 300MG A 200461 003 Sep 27, 2012 Dec DISC

LACTULOSE

SOLUTION;ORAL

LACTULOSE

>D> AA MORTON GROVE 10GM/15ML A 074602 001 Nov 14, 1996 Dec CAHN

>A> AA WOCKHARDT BIO AG 10GM/15ML A 074602 001 Nov 14, 1996 Dec CAHN

SOLUTION;ORAL, RECTAL

GENERLAC

>D> AA MORTON GROVE PHARMS 10GM/15ML A 074603 001 Oct 31, 1996 Dec CAHN

>A> AA WOCKHARDT BIO AG 10GM/15ML A 074603 001 Oct 31, 1996 Dec CAHN

LANSOPRAZOLE

>D> TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING;ORAL

>D> LANSOPRAZOLE

>D> @ ANI PHARMS INC 15MG A 078730 001 Oct 15, 2010 Dec CDFR

>D> @ 30MG A 078730 002 Oct 15, 2010 Dec CDFR

>D> PREVACID

>D> AB + TAKEDA PHARMS USA 15MG N 021428 001 Aug 30, 2002 Dec CDFR

>D> AB +! 30MG N 021428 002 Aug 30, 2002 Dec CDFR

>A> TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

>A> LANSOPRAZOLE

>A> @ ANI PHARMS INC 15MG A 078730 001 Oct 15, 2010 Dec CDFR

>A> @ 30MG A 078730 002 Oct 15, 2010 Dec CDFR

>A> PREVACID

>A> AB + TAKEDA PHARMS USA 15MG N 021428 001 Aug 30, 2002 Dec CDFR

Page 14 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LANSOPRAZOLE

>A> TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

>A> PREVACID

>A> AB +! 30MG N 021428 002 Aug 30, 2002 Dec CDFR

LEVETIRACETAM

SOLUTION;ORAL

LEVETIRACETAM

>D> AA WOCKHARDT 100MG/ML A 090028 001 Mar 03, 2010 Dec CAHN

>A> AA WOCKHARDT BIO AG 100MG/ML A 090028 001 Mar 03, 2010 Dec CAHN

LEVOTHYROXINE SODIUM

CAPSULE;ORAL

TIROSINT

>A> + INSTITUT BIOCHIMIQUE 0.013MG N 021924 013 Aug 01, 2007 Dec CMS1

TABLET;ORAL

LEVO-T

>D> --> + ALARA PHARM --> 0.025MG N 021342 001 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.05MG N 021342 002 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.075MG N 021342 003 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.088MG N 021342 004 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.1MG N 021342 005 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.112MG N 021342 006 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.125MG N 021342 007 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.137MG N 021342 012 Dec 08, 2003 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.15MG N 021342 008 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.175MG N 021342 009 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> + --> 0.2MG N 021342 010 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>D> --> +! --> 0.3MG N 021342 011 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + CEDIPROF INC --> 0.025MG N 021342 001 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.05MG N 021342 002 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.075MG N 021342 003 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.088MG N 021342 004 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.1MG N 021342 005 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.112MG N 021342 006 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.125MG N 021342 007 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.137MG N 021342 012 Dec 08, 2003 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.15MG N 021342 008 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.175MG N 021342 009 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> + --> 0.2MG N 021342 010 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

>A> --> +! --> 0.3MG N 021342 011 Mar 01, 2002 Dec CAHN

AB1,AB2,AB

LIDOCAINE HYDROCHLORIDE

SOLUTION;ORAL

LIDOCAINE HYDROCHLORIDE

>D> AT WOCKHARDT 2% A 087872 001 Nov 18, 1982 Dec CAHN

>A> AT WOCKHARDT BIO AG 2% A 087872 001 Nov 18, 1982 Dec CAHN

SOLUTION;TOPICAL

LIDOCAINE HYDROCHLORIDE

>D> AT WOCKHARDT 4% A 087881 001 Nov 18, 1982 Dec CAHN

>A> AT WOCKHARDT BIO AG 4% A 087881 001 Nov 18, 1982 Dec CAHN

Page 15 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LINDANE
SHAMPOO;TOPICAL
LINDANE
>D> AT ! WOCKHARDT 1% A 088191 001 Sep 18, 1984 Dec CAHN
>A> AT ! WOCKHARDT BIO AG 1% A 088191 001 Sep 18, 1984 Dec CAHN

LITHIUM CITRATE
SYRUP;ORAL
LITHIUM CITRATE
>D> AA WOCKHARDT EQ 300MG CARBONATE/5ML A 070755 001 May 21, 1986 Dec CAHN
>A> AA WOCKHARDT BIO AG EQ 300MG CARBONATE/5ML A 070755 001 May 21, 1986 Dec CAHN

LOPERAMIDE HYDROCHLORIDE
CAPSULE;ORAL
LOPERAMIDE HYDROCHLORIDE
>A> @ FOSUN PHARMA 2MG A 072993 001 Aug 28, 1992 Dec CAHN
>D> @ SANDOZ 2MG A 072993 001 Aug 28, 1992 Dec CAHN

LORAZEPAM
INJECTABLE;INJECTION
LORAZEPAM
>D> AP SAGENT AGILA LLC 2MG/ML A 200217 001 Apr 04, 2017 Dec DISC
>A> @ 2MG/ML A 200217 001 Apr 04, 2017 Dec DISC
>D> AP 2MG/ML A 200542 001 Apr 28, 2017 Dec DISC
>A> @ 2MG/ML A 200542 001 Apr 28, 2017 Dec DISC
>D> AP 4MG/ML A 200217 002 Apr 04, 2017 Dec DISC
>A> @ 4MG/ML A 200217 002 Apr 04, 2017 Dec DISC
>D> AP 4MG/ML A 200542 002 Apr 28, 2017 Dec DISC
>A> @ 4MG/ML A 200542 002 Apr 28, 2017 Dec DISC
TABLET;ORAL
LORAZEPAM
>A> AB AUROLIFE PHARMA LLC 0.5MG A 203572 001 Dec 22, 2017 Dec NEWA
>A> AB 1MG A 203572 002 Dec 22, 2017 Dec NEWA
>A> AB 2MG A 203572 003 Dec 22, 2017 Dec NEWA

>A> MACIMORELIN
>A> SOLUTION;ORAL
>A> MACRILEN
>A> +! AETERNA ZENTARIS 0.5MG/ML N 205598 001 Dec 21, 2017 Dec NEWA

>A> MACIMORELIN ACETATE

>A> FOR SOLUTION;ORAL
>A> MACRILEN
>A> +! AETERNA ZENTARIS EQ 60MG BASE/POUCH N 205598 001 Dec 21, 2017 Dec NEWA

MEGESTROL ACETATE
SUSPENSION;ORAL
MEGESTROL ACETATE
>D> AB WOCKHARDT 40MG/ML A 076721 001 Nov 01, 2004 Dec CAHN
>A> AB WOCKHARDT BIO AG 40MG/ML A 076721 001 Nov 01, 2004 Dec CAHN

MELPHALAN HYDROCHLORIDE
INJECTABLE;INJECTION
MELPHALAN HYDROCHLORIDE
>D> AP + DR REDDYS LABS LTD EQ 50MG BASE/VIAL A 203655 001 Dec 08, 2017 Dec CRLD
>A> AP EQ 50MG BASE/VIAL A 203655 001 Dec 08, 2017 Dec CRLD
>A> AP FRESENIUS KABI USA EQ 50MG BASE/VIAL A 203393 001 Dec 22, 2017 Dec NEWA

MEPERIDINE HYDROCHLORIDE
INJECTABLE;INJECTION
MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE
>D> @ MALLINCKRODT INC 10MG/ML A 040163 001 May 12, 1997 Dec CAHN
>A> @ SPECGX LLC 10MG/ML A 040163 001 May 12, 1997 Dec CAHN
TABLET;ORAL
MEPERIDINE HYDROCHLORIDE
>D> AA MALLINCKRODT 50MG A 040352 001 Jun 13, 2000 Dec CAHN
>D> AA 100MG A 040352 002 Jun 13, 2000 Dec CAHN
>A> AA SPECGX LLC 50MG A 040352 001 Jun 13, 2000 Dec CAHN
>A> AA 100MG A 040352 002 Jun 13, 2000 Dec CAHN

Page 16 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MESNA
INJECTABLE;INTRAVENOUS
MESNA
>A> AP GLAND PHARMA LTD 100MG/ML A 206992 001 Dec 18, 2017 Dec NEWA

METAXALONE
TABLET;ORAL
METAXALONE
>A> COREPHARMA 400MG A 040486 001 Feb 27, 2015 Dec CAHN
>D> IMPAX LABS INC 400MG A 040486 001 Feb 27, 2015 Dec CAHN

METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
METFORMIN HYDROCHLORIDE
>A> AB2 NOSTRUM LABS INC 500MG A 203832 001 Dec 26, 2017 Dec NEWA
>A> AB2 1GM A 203832 002 Dec 26, 2017 Dec NEWA

METHADONE HYDROCHLORIDE
CONCENTRATE;ORAL
METHADOSE
>D> AA +! MALLINCKRODT INC 10MG/ML N 017116 002 Nov 25, 1981 Dec CAHN
>A> AA +! SPECGX LLC 10MG/ML N 017116 002 Nov 25, 1981 Dec CAHN
TABLET, FOR SUSPENSION;ORAL
METHADONE HYDROCHLORIDE
>D> AA MALLINCKRODT INC 40MG A 077142 001 Jul 12, 2005 Dec CAHN
>A> AA SPECGX LLC 40MG A 077142 001 Jul 12, 2005 Dec CAHN
METHADOSE
>D> AA MALLINCKRODT INC 40MG A 074184 001 Apr 29, 1993 Dec CAHN
>A> AA SPECGX LLC 40MG A 074184 001 Apr 29, 1993 Dec CAHN
TABLET;ORAL
METHADONE HYDROCHLORIDE
>D> AA MALLINCKRODT 5MG A 040517 001 Apr 27, 2004 Dec CAHN
>D> AA 10MG A 040517 002 Apr 27, 2004 Dec CAHN
>A> AA SPECGX LLC 5MG A 040517 001 Apr 27, 2004 Dec CAHN
>A> AA 10MG A 040517 002 Apr 27, 2004 Dec CAHN
METHADOSE
>D> AA MALLINCKRODT 5MG A 040050 001 Apr 15, 1993 Dec CAHN
>D> AA 10MG A 040050 002 Apr 15, 1993 Dec CAHN
>A> AA SPECGX LLC 5MG A 040050 001 Apr 15, 1993 Dec CAHN
>A> AA 10MG A 040050 002 Apr 15, 1993 Dec CAHN

METHOTREXATE
SOLUTION;SUBCUTANEOUS
OTREXUP
>D> @ ANTARES PHARMA INC 7.5MG/0.4ML (7.5MG/0.4ML) N 204824 005 Nov 07, 2014 Dec CRLD
>A> + @ 7.5MG/0.4ML (7.5MG/0.4ML) N 204824 005 Nov 07, 2014 Dec CRLD
>D> + 10MG/0.4ML (10MG/0.4ML) N 204824 001 Oct 11, 2013 Dec CHRS
>A> +! 10MG/0.4ML (10MG/0.4ML) N 204824 001 Oct 11, 2013 Dec CHRS
>D> + 12.5MG/0.4ML (12.5MG/0.4ML) N 204824 006 Mar 24, 2016 Dec CHRS
>A> +! 12.5MG/0.4ML (12.5MG/0.4ML) N 204824 006 Mar 24, 2016 Dec CHRS
>D> + 15MG/0.4ML (15MG/0.4ML) N 204824 002 Oct 11, 2013 Dec CHRS
>A> +! 15MG/0.4ML (15MG/0.4ML) N 204824 002 Oct 11, 2013 Dec CHRS
>D> + 17.5MG/0.4ML (17.5MG/0.4ML) N 204824 007 Mar 24, 2016 Dec CHRS
>A> +! 17.5MG/0.4ML (17.5MG/0.4ML) N 204824 007 Mar 24, 2016 Dec CHRS
>D> + 20MG/0.4ML (20MG/0.4ML) N 204824 003 Oct 11, 2013 Dec CHRS
>A> +! 20MG/0.4ML (20MG/0.4ML) N 204824 003 Oct 11, 2013 Dec CHRS
>D> + 22.5MG/0.4ML (22.5MG/0.4ML) N 204824 008 Mar 24, 2016 Dec CHRS
>A> +! 22.5MG/0.4ML (22.5MG/0.4ML) N 204824 008 Mar 24, 2016 Dec CHRS
RASUVO
>D> MEDAC PHARMA INC 7.5MG/0.15ML (7.5MG/0.15ML) N 205776 001 Jul 10, 2014 Dec CRLD
>A> + 7.5MG/0.15ML (7.5MG/0.15ML) N 205776 001 Jul 10, 2014 Dec CRLD
>D> 10MG/0.20ML (10MG/0.20ML) N 205776 002 Jul 10, 2014 Dec CRLD
>A> + 10MG/0.20ML (10MG/0.20ML) N 205776 002 Jul 10, 2014 Dec CRLD
>D> 12.5MG/0.25ML (12.5MG/0.25ML) N 205776 003 Jul 10, 2014 Dec CRLD
>A> + 12.5MG/0.25ML (12.5MG/0.25ML) N 205776 003 Jul 10, 2014 Dec CRLD
>D> 15MG/0.30ML (15MG/0.30ML) N 205776 004 Jul 10, 2014 Dec CRLD
>A> + 15MG/0.30ML (15MG/0.30ML) N 205776 004 Jul 10, 2014 Dec CRLD
>D> 17.5MG/0.35ML (17.5MG/0.35ML) N 205776 005 Jul 10, 2014 Dec CRLD
>A> + 17.5MG/0.35ML (17.5MG/0.35ML) N 205776 005 Jul 10, 2014 Dec CRLD
>D> 20MG/0.4ML (20MG/0.4ML) N 205776 006 Jul 10, 2014 Dec CRLD

Page 17 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METHOTREXATE

SOLUTION;SUBCUTANEOUS

RASUVO

>A> +
20MG/0.4ML (20MG/0.4ML)
N 205776 006 Jul 10, 2014 Dec CRLD

>D>
22.5MG/0.45ML (22.5MG/0.45ML)
N 205776 007 Jul 10, 2014 Dec CRLD

>A> +
22.5MG/0.45ML (22.5MG/0.45ML)
N 205776 007 Jul 10, 2014 Dec CRLD

>D>
25MG/0.5ML (25MG/0.5ML)
N 205776 008 Jul 10, 2014 Dec CRLD

>A> +
25MG/0.5ML (25MG/0.5ML)
N 205776 008 Jul 10, 2014 Dec CRLD

>D> @
27.5MG/0.55ML (27.5MG/0.55ML)
N 205776 009 Jul 10, 2014 Dec CRLD

>A> + @
27.5MG/0.55ML (27.5MG/0.55ML)
N 205776 009 Jul 10, 2014 Dec CRLD

>D>
30MG/0.6ML (30MG/0.6ML)
N 205776 010 Jul 10, 2014 Dec CRLD

>A> +
30MG/0.6ML (30MG/0.6ML)
N 205776 010 Jul 10, 2014 Dec CRLD

METHOTREXATE SODIUM

TABLET;ORAL

METHOTREXATE SODIUM

>A> AB AMNEAL PHARMS
EQ 2.5MG BASE
A 210040 001 Dec 22, 2017 Dec NEWA

METHYCLOTHIAZIDE

TABLET;ORAL

METHYCLOTHIAZIDE

>A> @ FOSUN PHARMA
2.5MG
A 089835 001 Aug 18, 1988 Dec CAHN

>A> @
5MG
A 089837 001 Aug 18, 1988 Dec CAHN

>D> @ SANDOZ
2.5MG
A 089835 001 Aug 18, 1988 Dec CAHN

>D> @
5MG
A 089837 001 Aug 18, 1988 Dec CAHN

METHYLDOPA

TABLET;ORAL

METHYLDOPA

>A> @ FOSUN PHARMA
250MG
N 018934 001 Jun 29, 1984 Dec CAHN

>A> @
500MG
N 018934 002 Jun 29, 1984 Dec CAHN

>D> @ SANDOZ
250MG
N 018934 001 Jun 29, 1984 Dec CAHN

>D> @
500MG
N 018934 002 Jun 29, 1984 Dec CAHN

METHYLPHENIDATE HYDROCHLORIDE

CAPSULE, EXTENDED RELEASE;ORAL

METHYLPHENIDATE HYDROCHLORIDE

>D> AB2 MALLINCKRODT INC
10MG
A 203583 001 Sep 29, 2015 Dec CAHN

>D> AB2
20MG
A 203583 002 Sep 29, 2015 Dec CAHN

>D> AB2
30MG
A 203583 003 Sep 29, 2015 Dec CAHN

>D> AB2
40MG
A 203583 004 Sep 29, 2015 Dec CAHN

>D> AB2
50MG
A 203583 005 Sep 29, 2015 Dec CAHN

>D> AB2
60MG
A 203583 006 Sep 29, 2015 Dec CAHN

>A> AB2 SPECGX LLC
10MG
A 203583 001 Sep 29, 2015 Dec CAHN

>A> AB2
20MG
A 203583 002 Sep 29, 2015 Dec CAHN

>A> AB2
30MG
A 203583 003 Sep 29, 2015 Dec CAHN

>A> AB2
40MG
A 203583 004 Sep 29, 2015 Dec CAHN

>A> AB2
50MG
A 203583 005 Sep 29, 2015 Dec CAHN

>A> AB2
60MG
A 203583 006 Sep 29, 2015 Dec CAHN

SOLUTION;ORAL

METHYLIN

>D> AA +! MALLINCKRODT
5MG/5ML
N 021419 001 Dec 19, 2002 Dec CAHN

>D> AA +!
10MG/5ML
N 021419 002 Dec 19, 2002 Dec CAHN

>A> AA +! SPECGX LLC
5MG/5ML
N 021419 001 Dec 19, 2002 Dec CAHN

>A> AA +!
10MG/5ML
N 021419 002 Dec 19, 2002 Dec CAHN

TABLET, CHEWABLE;ORAL

METHYLIN

>D> + @ MALLINCKRODT
2.5MG
N 021475 001 Apr 15, 2003 Dec CAHN

>D> + @
5MG
N 021475 002 Apr 15, 2003 Dec CAHN

>D> + @
10MG
N 021475 003 Apr 15, 2003 Dec CAHN

>A> + @ SPECGX LLC
2.5MG
N 021475 001 Apr 15, 2003 Dec CAHN

>A> + @
5MG
N 021475 002 Apr 15, 2003 Dec CAHN

>A> + @
10MG
N 021475 003 Apr 15, 2003 Dec CAHN

METHYLPHENIDATE HYDROCHLORIDE

>A> AB ASCENT PHARMS INC
2.5MG
A 210354 001 Dec 29, 2017 Dec NEWA

>A> AB
5MG
A 210354 002 Dec 29, 2017 Dec NEWA

>A> AB
10MG
A 210354 003 Dec 29, 2017 Dec NEWA

TABLET, EXTENDED RELEASE;ORAL

METHYLIN ER

>D> AB MALLINCKRODT INC
10MG
A 075629 001 May 09, 2000 Dec CAHN

Page 18 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
METHYLIN ER
>D> AB 20MG A 075629 002 May 09, 2000 Dec CAHN
>A> AB SPECGX LLC 10MG A 075629 001 May 09, 2000 Dec CAHN
>A> AB 20MG A 075629 002 May 09, 2000 Dec CAHN
METHYLPHENIDATE HYDROCHLORIDE
>A> AB COREPHARMA 18MG A 208607 001 Jul 14, 2017 Dec CAHN
>A> AB 27MG A 208607 002 Jul 14, 2017 Dec CAHN
>A> AB 36MG A 208607 003 Jul 14, 2017 Dec CAHN
>A> AB 54MG A 208607 004 Jul 14, 2017 Dec CAHN
>D> AB IMPAX LABS INC 18MG A 208607 001 Jul 14, 2017 Dec CAHN
>D> AB 27MG A 208607 002 Jul 14, 2017 Dec CAHN
>D> AB 36MG A 208607 003 Jul 14, 2017 Dec CAHN
>D> AB 54MG A 208607 004 Jul 14, 2017 Dec CAHN
>D> BX MALLINCKRODT INC 27MG A 202608 001 Dec 28, 2012 Dec CAHN
>D> BX 36MG A 202608 002 Dec 28, 2012 Dec CAHN
>D> BX 54MG A 202608 003 Dec 28, 2012 Dec CAHN
>A> BX SPECGX LLC 27MG A 202608 001 Dec 28, 2012 Dec CAHN
>A> BX 36MG A 202608 002 Dec 28, 2012 Dec CAHN
>A> BX 54MG A 202608 003 Dec 28, 2012 Dec CAHN
TABLET;ORAL
METHYLPHENIDATE HYDROCHLORIDE
>A> AB COREPHARMA 5MG A 091159 001 Mar 12, 2014 Dec CAHN
>A> AB 10MG A 091159 002 Mar 12, 2014 Dec CAHN
>A> AB 20MG A 091159 003 Mar 12, 2014 Dec CAHN
>D> AB IMPAX LABS INC 5MG A 091159 001 Mar 12, 2014 Dec CAHN
>D> AB 10MG A 091159 002 Mar 12, 2014 Dec CAHN
>D> AB 20MG A 091159 003 Mar 12, 2014 Dec CAHN
>D> AB MALLINCKRODT 5MG A 040300 001 Nov 27, 1998 Dec CAHN
>D> AB 10MG A 040300 002 Nov 27, 1998 Dec CAHN
>D> AB 20MG A 040300 003 Nov 27, 1998 Dec CAHN
>A> AB SPECGX LLC 5MG A 040300 001 Nov 27, 1998 Dec CAHN
>A> AB 10MG A 040300 002 Nov 27, 1998 Dec CAHN
>A> AB 20MG A 040300 003 Nov 27, 1998 Dec CAHN

METOCLOPRAMIDE HYDROCHLORIDE
SOLUTION;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
>D> AA ! WOCKHARDT EQ 5MG BASE/5ML A 074703 001 Oct 31, 1997 Dec CAHN
>A> AA ! WOCKHARDT BIO AG EQ 5MG BASE/5ML A 074703 001 Oct 31, 1997 Dec CAHN
TABLET;ORAL
METOCLOPRAMIDE HYDROCHLORIDE
>A> @ FOSUN PHARMA EQ 5MG BASE A 074478 001 Oct 05, 1995 Dec CAHN
>A> @ EQ 10MG BASE A 072215 001 Jan 30, 1990 Dec CAHN
>A> @ EQ 10MG BASE A 074478 002 Oct 05, 1995 Dec CAHN
>D> @ SANDOZ EQ 5MG BASE A 074478 001 Oct 05, 1995 Dec CAHN
>D> @ EQ 10MG BASE A 072215 001 Jan 30, 1990 Dec CAHN
>D> @ EQ 10MG BASE A 074478 002 Oct 05, 1995 Dec CAHN

METOPROLOL TARTRATE
TABLET;ORAL
METOPROLOL TARTRATE
>A> @ FOSUN PHARMA 50MG A 073288 001 Mar 25, 1994 Dec CAHN
>A> @ 100MG A 073289 001 Mar 25, 1994 Dec CAHN
>D> @ SANDOZ 50MG A 073288 001 Mar 25, 1994 Dec CAHN
>D> @ 100MG A 073289 001 Mar 25, 1994 Dec CAHN

METRONIDAZOLE
TABLET;ORAL
METRONIDAZOLE
>A> AB INNOGENIX 500MG A 070772 002 Jul 16, 1986 Dec CMS1

MOMETASONE FUROATE
IMPLANT;IMPLANTATION
>A> SINUVA
>A> + INTERSECT ENT INC 1.35MG N 209310 001 Dec 08, 2017 Dec NEWA

Page 19 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MORPHINE SULFATE

INJECTABLE;INJECTION

MORPHINE SULFATE

>D> @ MALLINCKRODT INC 1MG/ML N 020631 001 Jul 03, 1996 Dec CAHN

>D> @ 2MG/ML N 020631 002 Jul 03, 1996 Dec CAHN

>A> @ SPECGX LLC 1MG/ML N 020631 001 Jul 03, 1996 Dec CAHN

>A> @ 2MG/ML N 020631 002 Jul 03, 1996 Dec CAHN

SOLUTION;ORAL

MORPHINE SULFATE

>D> AA MALLINCKRODT INC 100MG/5ML A 202348 001 Jul 15, 2011 Dec CAHN

>A> AA SPECGX LLC 100MG/5ML A 202348 001 Jul 15, 2011 Dec CAHN

TABLET, EXTENDED RELEASE;ORAL

MORPHINE SULFATE

>D> AB MALLINCKRODT 15MG A 076412 001 Jul 31, 2003 Dec CAHN

>D> AB 30MG A 076412 002 Jul 31, 2003 Dec CAHN

>D> AB 60MG A 076412 003 Jul 31, 2003 Dec CAHN

>D> AB 100MG A 076438 001 Jul 03, 2003 Dec CAHN

>D> AB 200MG A 076438 002 Jul 03, 2003 Dec CAHN

>A> AB SPECGX LLC 15MG A 076412 001 Jul 31, 2003 Dec CAHN

>A> AB 30MG A 076412 002 Jul 31, 2003 Dec CAHN

>A> AB 60MG A 076412 003 Jul 31, 2003 Dec CAHN

>A> AB 100MG A 076438 001 Jul 03, 2003 Dec CAHN

>A> AB 200MG A 076438 002 Jul 03, 2003 Dec CAHN

MOXIFLOXACIN HYDROCHLORIDE

SOLUTION;IV (INFUSION)

>D> AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER

>D> AP +! BAYER HLTHCARE 400MG/250ML (1.6MG/ML) N 021277 001 Nov 30, 2001 Dec DISC

>A> + @ 400MG/250ML (1.6MG/ML) N 021277 001 Nov 30, 2001 Dec DISC

MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER

>D> AP MYLAN LABS LTD 400MG/250ML (1.6MG/ML) A 205833 001 May 05, 2017 Dec CHRS

>A> ! 400MG/250ML (1.6MG/ML) A 205833 001 May 05, 2017 Dec CHRS

NABUMETONE

TABLET;ORAL

NABUMETONE

>D> @ DR REDDYS LABS LTD 500MG A 078420 001 Sep 24, 2008 Dec CAHN

>D> @ 750MG A 078420 002 Sep 24, 2008 Dec CAHN

>A> @ SCIEGEN PHARMS INC 500MG A 078420 001 Sep 24, 2008 Dec CAHN

>A> @ 750MG A 078420 002 Sep 24, 2008 Dec CAHN

NALTREXONE HYDROCHLORIDE

TABLET;ORAL

NALTREXONE HYDROCHLORIDE

>D> MALLINCKRODT 25MG A 076264 001 Mar 22, 2002 Dec CAHN

>D> AB ! 50MG A 076264 002 Mar 22, 2002 Dec CAHN

>D> 100MG A 076264 003 Mar 22, 2002 Dec CAHN

>A> SPECGX LLC 25MG A 076264 001 Mar 22, 2002 Dec CAHN

>A> AB ! 50MG A 076264 002 Mar 22, 2002 Dec CAHN

>A> 100MG A 076264 003 Mar 22, 2002 Dec CAHN

>A> NETARSUDIL DIMESYLATE

>A> SOLUTION/DROPS;OPHTHALMIC

>A> RHOPRESSA

>A> +! AERIE PHARMS INC EQ 0.02% BASE N 208254 001 Dec 18, 2017 Dec NEWA

NIFEDIPINE

TABLET, EXTENDED RELEASE;ORAL

NIFEDIPINE

>A> AB2 ZYDUS PHARMS USA INC 30MG A 210012 001 Dec 19, 2017 Dec NEWA

>A> AB2 60MG A 210012 002 Dec 19, 2017 Dec NEWA

>A> AB2 90MG A 210012 003 Dec 19, 2017 Dec NEWA

NORFLOXACIN

TABLET;ORAL

NOROXIN

>D> @ MERCK 400MG N 019384 002 Oct 31, 1986 Dec CRLD

>A> + @ 400MG N 019384 002 Oct 31, 1986 Dec CRLD

Page 20 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

NORTRIPTYLINE HYDROCHLORIDE

CAPSULE;ORAL

PAMELOR

>D> AB + MALLINCKRODT LLC EQ 10MG BASE N 018013 001 Aug 01, 1977 Dec CAHN

>D> AB + EQ 25MG BASE N 018013 002 Aug 01, 1977 Dec CAHN

>D> AB + EQ 50MG BASE N 018013 004 Jun 14, 1979 Dec CAHN

>D> AB +! EQ 75MG BASE N 018013 003 Jun 14, 1979 Dec CAHN

>A> AB + SPECGX LLC EQ 10MG BASE N 018013 001 Aug 01, 1977 Dec CAHN

>A> AB + EQ 25MG BASE N 018013 002 Aug 01, 1977 Dec CAHN

>A> AB + EQ 50MG BASE N 018013 004 Jun 14, 1979 Dec CAHN

>A> AB +! EQ 75MG BASE N 018013 003 Jun 14, 1979 Dec CAHN

SOLUTION;ORAL

PAMELOR

>D> @ MALLINCKRODT INC EQ 10MG BASE/5ML N 018012 001 Aug 01, 1977 Dec CAHN

>A> @ SPECGX LLC EQ 10MG BASE/5ML N 018012 001 Aug 01, 1977 Dec CAHN

NYSTATIN

SUSPENSION;ORAL

NILSTAT

>D> @ GLENMARK GENERICS 100,000 UNITS/ML N 050299 001 Apr 14, 1971 Dec CRLD

>A> + @ 100,000 UNITS/ML N 050299 001 Apr 14, 1971 Dec CRLD

NYSTATIN

>D> AA ! WOCKHARDT 100,000 UNITS/ML A 062512 001 Oct 29, 1984 Dec CAHN

>A> AA ! WOCKHARDT BIO AG 100,000 UNITS/ML A 062512 001 Oct 29, 1984 Dec CAHN

NYSTATIN; TRIAMCINOLONE ACETONIDE

CREAM;TOPICAL

NYSTATIN AND TRIAMCINOLONE ACETONIDE

>A> AT CROWN LABS INC 100,000 UNITS/GM;0.1% A 207730 001 Dec 26, 2017 Dec NEWA

OINTMENT;TOPICAL

NYSTATIN AND TRIAMCINOLONE ACETONIDE

>A> AT CROWN LABS INC 100,000 UNITS/GM;0.1% A 207731 001 Dec 26, 2017 Dec NEWA

ORLISTAT

CAPSULE;ORAL

XENICAL

>A> +! CHEPLAPHARM 120MG N 020766 001 Apr 23, 1999 Dec CAHN

>D> +! HOFFMANN LA ROCHE 120MG N 020766 001 Apr 23, 1999 Dec CAHN

OSELTAMIVIR PHOSPHATE

CAPSULE;ORAL

OSELTAMIVIR PHOSPHATE

>A> AB LUPIN ATLANTIS EQ 30MG BASE A 208348 001 Jan 09, 2018 Dec NEWA

>A> AB EQ 45MG BASE A 208348 002 Jan 09, 2018 Dec NEWA

>A> AB EQ 75MG BASE A 208348 003 Jan 09, 2018 Dec NEWA

OXYBUTYNIN CHLORIDE

SYRUP;ORAL

OXYBUTYNIN CHLORIDE

>D> AA ! WOCKHARDT 5MG/5ML A 074868 001 Feb 12, 1997 Dec CAHN

>A> AA ! WOCKHARDT BIO AG 5MG/5ML A 074868 001 Feb 12, 1997 Dec CAHN

TABLET;ORAL

OXYBUTYNIN CHLORIDE

>A> AB ABHAI LLC 5MG A 209335 001 Dec 22, 2017 Dec NEWA

>A> AB APPCO PHARMA LLC 5MG A 209025 001 Dec 21, 2017 Dec NEWA

OXYCODONE HYDROCHLORIDE

TABLET;ORAL

OXYCODONE HYDROCHLORIDE

>D> AB MALLINCKRODT INC 5MG A 076758 003 Mar 19, 2007 Dec CAHN

>D> AB 15MG A 076758 001 Jun 30, 2004 Dec CAHN

>D> AB 30MG A 076758 002 Jun 30, 2004 Dec CAHN

>A> AB SPECGX LLC 5MG A 076758 003 Mar 19, 2007 Dec CAHN

>A> AB 15MG A 076758 001 Jun 30, 2004 Dec CAHN

>A> AB 30MG A 076758 002 Jun 30, 2004 Dec CAHN

ROXICODONE

>D> AB + MALLINCKRODT INC 5MG N 021011 003 May 15, 2009 Dec CAHN

>D> AB +! 15MG N 021011 001 Aug 31, 2000 Dec CAHN

>D> AB + 30MG N 021011 002 Aug 31, 2000 Dec CAHN

>A> AB + SPECGX LLC 5MG N 021011 003 May 15, 2009 Dec CAHN

>A> AB +! 15MG N 021011 001 Aug 31, 2000 Dec CAHN

Page 21 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

OXYCODONE HYDROCHLORIDE

TABLET;ORAL

ROXICODONE

>A> AB + 30MG N 021011 002 Aug 31, 2000 Dec CAHN

OXYMORPHONE HYDROCHLORIDE

TABLET, EXTENDED RELEASE;ORAL

OXYMORPHONE HYDROCHLORIDE

>D> AB MALLINCKRODT INC 5MG A 202946 001 Jun 27, 2014 Dec CAHN

>D> AB 7.5MG A 202946 002 Jun 27, 2014 Dec CAHN

>D> AB 10MG A 202946 003 Jun 27, 2014 Dec CAHN

>D> AB 15MG A 202946 004 Jun 27, 2014 Dec CAHN

>D> AB 20MG A 202946 005 Jun 27, 2014 Dec CAHN

>D> AB 30MG A 202946 006 Jun 27, 2014 Dec CAHN

>D> AB 40MG A 202946 007 Jun 27, 2014 Dec CAHN

>A> AB SPECGX LLC 5MG A 202946 001 Jun 27, 2014 Dec CAHN

>A> AB 7.5MG A 202946 002 Jun 27, 2014 Dec CAHN

>A> AB 10MG A 202946 003 Jun 27, 2014 Dec CAHN

>A> AB 15MG A 202946 004 Jun 27, 2014 Dec CAHN

>A> AB 20MG A 202946 005 Jun 27, 2014 Dec CAHN

>A> AB 30MG A 202946 006 Jun 27, 2014 Dec CAHN

>A> AB 40MG A 202946 007 Jun 27, 2014 Dec CAHN

TABLET;ORAL

OXYMORPHONE HYDROCHLORIDE

>D> AB MALLINCKRODT INC 5MG A 202321 001 Apr 25, 2013 Dec CAHN

>D> AB 10MG A 202321 002 Apr 25, 2013 Dec CAHN

>A> AB SPECGX LLC 5MG A 202321 001 Apr 25, 2013 Dec CAHN

>A> AB 10MG A 202321 002 Apr 25, 2013 Dec CAHN

>A> OZENOXACIN

>A> CREAM;TOPICAL

>A> XEPI

>A> +! FERRER INTERNACIONAL 1% N 208945 001 Dec 11, 2017 Dec NEWA

PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

CAPSULE, DELAYED RELEASE;ORAL

ZENPEP

>D> + FOREST LABS INC 218,000USP UNITS; 40,00USP N 022210 007 Mar 25, 2014 Dec CPOT

UNITS; 136,000 USP UNITS

>A> + 168,000USP UNITS;40,000USP N 022210 007 Mar 25, 2014 Dec CPOT

UNITS;126,000USP UNITS

>D> + 10,000USP UNITS;16,000USP N 022210 005 Jun 15, 2011 Dec CPOT

UNITS;3,000USP UNITS

>D> + 10,000USP UNITS;34,000USP N 022210 002 Aug 27, 2009 Dec CPOT

UNITS;55,000USP UNITS

>A> + 14,000USP UNITS;3,000USP N 022210 005 Jun 15, 2011 Dec CPOT

UNITS;10,000USP UNITS

>D> + 15,000USP UNITS;51,000USP N 022210 003 Aug 27, 2009 Dec CPOT

UNITS;82,000USP UNITS

>D> + 17,000USP UNITS;27,000USP N 022210 001 Aug 27, 2009 Dec CPOT

UNITS;5,000USP UNITS

>A> + 24,000USP UNITS;5,000USP N 022210 001 Aug 27, 2009 Dec CPOT

UNITS;17,000USP UNITS

>A> + 42,000USP UNITS;10,000USP N 022210 002 Aug 27, 2009 Dec CPOT

UNITS;32,000USP UNITS

>A> + 63,000USP UNITS;15,000USP N 022210 003 Aug 27, 2009 Dec CPOT

UNITS;47,000USP UNITS

>A> + 84,000USP UNITS;20,000USP N 022210 004 Aug 27, 2009 Dec CPOT

UNITS;63,000USP UNITS

>A> +! 105,000USP UNITS;25,000USP N 022210 006 Jul 13, 2011 Dec CPOT

UNITS;79,000USP UNITS

>D> + 109,000USP UNITS;20,000USP N 022210 004 Aug 27, 2009 Dec CPOT

UNITS;68,000USP UNITS

>D> +! 136,000USP UNITS;25,000USP N 022210 006 Jul 13, 2011 Dec CPOT

UNITS;85,000USP UNITS

PANCURONIUM BROMIDE

INJECTABLE;INJECTION

PAVULON

>D> @ ORGANON USA INC 1MG/ML N 017015 002 Sep 14, 1973 Dec CRLD

>A> + @ 1MG/ML N 017015 002 Sep 14, 1973 Dec CRLD

>D> @ 2MG/ML N 017015 001 Oct 24, 1972 Dec CRLD

>A> + @ 2MG/ML N 017015 001 Oct 24, 1972 Dec CRLD

Page 22 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PHENDIMETRAZINE TARTRATE

TABLET;ORAL

PHENDIMETRAZINE TARTRATE

>A> AA ELITE LABS INC 35MG
A 203600 001 Dec 27, 2017 Dec NEWA

PHENYTOIN

SUSPENSION;ORAL

PHENYTOIN

>D> AB WOCKHARDT 125MG/5ML
A 040420 001 Apr 19, 2002 Dec CAHN

>A> AB WOCKHARDT EU OPERATN 125MG/5ML
A 040420 001 Apr 19, 2002 Dec CAHN

PIROXICAM

CAPSULE;ORAL

PIROXICAM

>A> AB + MICRO LABS 10MG
A 206152 001 Dec 29, 2017 Dec NEWA

>A> AB + 20MG
A 206152 002 Dec 29, 2017 Dec NEWA

POLIDOCANOL

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

VARITHENA

>A> +! PROVENSIS 77.5MG/7.75ML (10MG/ML)
N 205098 002 Dec 21, 2017 Dec NEWA

POTASSIUM CITRATE

TABLET, EXTENDED RELEASE;ORAL

POTASSIUM CITRATE

>A> AB COREPHARMA 5MEQ
A 077440 001 Jun 09, 2006 Dec CAHN

>A> AB 10MEQ
A 077440 002 Jun 09, 2006 Dec CAHN

>D> AB IMPAX LABS INC 5MEQ
A 077440 001 Jun 09, 2006 Dec CAHN

>D> AB 10MEQ
A 077440 002 Jun 09, 2006 Dec CAHN

PREDNISOLONE

SYRUP;ORAL

PREDNISOLONE

>D> AA WOCKHARDT 15MG/5ML
A 040313 001 Sep 10, 2003 Dec CAHN

>A> AA WOCKHARDT BIO AG 15MG/5ML
A 040313 001 Sep 10, 2003 Dec CAHN

PREDNISOLONE SODIUM PHOSPHATE

SOLUTION;ORAL

PREDNISOLONE SODIUM PHOSPHATE

>D> AA WOCKHARDT EQ 5MG BASE/5ML
A 075099 001 Jun 28, 2002 Dec CAHN

>A> AA WOCKHARDT BIO AG EQ 5MG BASE/5ML
A 075099 001 Jun 28, 2002 Dec CAHN

PROMETHAZINE HYDROCHLORIDE

SYRUP;ORAL

PROMETHAZINE PLAIN

>D> AA ! WOCKHARDT 6.25MG/5ML
A 087953 001 Nov 15, 1982 Dec CAHN

>A> AA ! WOCKHARDT BIO AG 6.25MG/5ML
A 087953 001 Nov 15, 1982 Dec CAHN

PROPRANOLOL HYDROCHLORIDE

TABLET;ORAL

PROPRANOLOL HYDROCHLORIDE

>A> AB VINTAGE PHARMS 10MG
A 070221 002 Aug 01, 1986 Dec CMS1

>A> AB 20MG
A 070221 003 Aug 01, 1986 Dec CMS1

>A> AB 40MG
A 070221 004 Aug 01, 1986 Dec CMS1

>A> AB 60MG
A 070221 005 Sep 24, 1986 Dec CMS1

QUINAPRIL HYDROCHLORIDE

TABLET;ORAL

QUINAPRIL HYDROCHLORIDE

>A> @ FOSUN PHARMA EQ 5MG BASE
A 076803 001 Mar 02, 2005 Dec CAHN

>A> @ EQ 10MG BASE
A 076803 002 Mar 02, 2005 Dec CAHN

>A> @ EQ 20MG BASE
A 076803 003 Mar 02, 2005 Dec CAHN

>A> @ EQ 40MG BASE
A 076803 004 Mar 02, 2005 Dec CAHN

>D> @ SANDOZ EQ 5MG BASE
A 076803 001 Mar 02, 2005 Dec CAHN

>D> @ EQ 10MG BASE
A 076803 002 Mar 02, 2005 Dec CAHN

>D> @ EQ 20MG BASE
A 076803 003 Mar 02, 2005 Dec CAHN

>D> @ EQ 40MG BASE
A 076803 004 Mar 02, 2005 Dec CAHN

Page 23 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

RAMIPRIL

CAPSULE;ORAL

RAMIPRIL

>A> @ FOSUN PHARMA
1.25MG
A 077514 001 Jun 18, 2008 Dec CAHN

>A> @
2.5MG
A 077514 002 Jun 18, 2008 Dec CAHN

>A> @
5MG
A 077514 003 Jun 18, 2008 Dec CAHN

>A> @
10MG
A 077514 004 Jun 18, 2008 Dec CAHN

>D> @ SANDOZ
1.25MG
A 077514 001 Jun 18, 2008 Dec CAHN

>D> @
2.5MG
A 077514 002 Jun 18, 2008 Dec CAHN

>D> @
5MG
A 077514 003 Jun 18, 2008 Dec CAHN

>D> @
10MG
A 077514 004 Jun 18, 2008 Dec CAHN

RANITIDINE HYDROCHLORIDE

TABLET;ORAL

RANITIDINE HYDROCHLORIDE

>D> AB WOCKHARDT
EQ 150MG BASE
A 075208 001 Dec 17, 1998 Dec CAHN

>D> AB
EQ 300MG BASE
A 075208 002 Dec 17, 1998 Dec CAHN

>A> AB WOCKHARDT LTD
EQ 150MG BASE
A 075208 001 Dec 17, 1998 Dec CAHN

>A> AB
EQ 300MG BASE
A 075208 002 Dec 17, 1998 Dec CAHN

RISPERIDONE

TABLET, ORALLY DISINTEGRATING;ORAL

RISPERIDONE

>D> AB MYLAN PHARMS INC
0.25MG
A 091537 006 Feb 12, 2013 Dec DISC

>A> @
0.25MG
A 091537 006 Feb 12, 2013 Dec DISC

>D> AB
0.5MG
A 091537 001 Mar 30, 2011 Dec DISC

>A> @
0.5MG
A 091537 001 Mar 30, 2011 Dec DISC

>D> AB
1MG
A 091537 002 Mar 30, 2011 Dec DISC

>A> @
1MG
A 091537 002 Mar 30, 2011 Dec DISC

>D> AB
2MG
A 091537 003 Mar 30, 2011 Dec DISC

>A> @
2MG
A 091537 003 Mar 30, 2011 Dec DISC

>D> AB
3MG
A 091537 004 Mar 30, 2011 Dec DISC

>A> @
3MG
A 091537 004 Mar 30, 2011 Dec DISC

>D> AB
4MG
A 091537 005 Mar 30, 2011 Dec DISC

>A> @
4MG
A 091537 005 Mar 30, 2011 Dec DISC

>D> AB PAR PHARM
0.25MG
A 077494 001 Apr 30, 2009 Dec CTEC

>A>
0.25MG
A 077494 001 Apr 30, 2009 Dec CTEC

SELENIUM SULFIDE

LOTION/SHAMPOO;TOPICAL

SELENIUM SULFIDE

>D> AT WOCKHARDT
2.5%
A 088228 001 Sep 01, 1983 Dec CAHN

>A> AT WOCKHARDT BIO AG
2.5%
A 088228 001 Sep 01, 1983 Dec CAHN

>A> SEMAGLUTIDE

>A> SOLUTION;SUBCUTANEOUS

>A> OZEMPIC

>A> +! NOVO NORDISK INC
2MG/1.5ML (1.34MG/ML)
N 209637 001 Dec 05, 2017 Dec NEWA

SERTRALINE HYDROCHLORIDE

TABLET;ORAL

SERTRALINE HYDROCHLORIDE

>D> @ DR REDDYS LABS LTD
EQ 25MG BASE
A 076442 001 Apr 30, 2007 Dec CAHN

>D> @
EQ 50MG BASE
A 076442 002 Apr 30, 2007 Dec CAHN

>D> @
EQ 100MG BASE
A 076442 003 Apr 30, 2007 Dec CAHN

>A> @ SCIEGEN PHARMS INC
EQ 25MG BASE
A 076442 001 Apr 30, 2007 Dec CAHN

>A> @
EQ 50MG BASE
A 076442 002 Apr 30, 2007 Dec CAHN

>A> @
EQ 100MG BASE
A 076442 003 Apr 30, 2007 Dec CAHN

SIMVASTATIN

TABLET;ORAL

SIMVASTATIN

>A> @ FOSUN PHARMA
5MG
A 077766 001 Dec 20, 2006 Dec CAHN

>A> @
10MG
A 077766 002 Dec 20, 2006 Dec CAHN

>A> @
20MG
A 077766 003 Dec 20, 2006 Dec CAHN

>A> @
40MG
A 077766 004 Dec 20, 2006 Dec CAHN

>A> @
80MG
A 077766 005 Dec 20, 2006 Dec CAHN

>D> @ SANDOZ INC
5MG
A 077766 001 Dec 20, 2006 Dec CAHN

>D> @
10MG
A 077766 002 Dec 20, 2006 Dec CAHN

>D> @
20MG
A 077766 003 Dec 20, 2006 Dec CAHN

Page 24 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

SIMVASTATIN

TABLET;ORAL

SIMVASTATIN

>D> @ 40MG A 077766 004 Dec 20, 2006 Dec CAHN

>D> @ 80MG A 077766 005 Dec 20, 2006 Dec CAHN

SODIUM FLUORIDE F-18

INJECTABLE;INTRAVENOUS

SODIUM FLUORIDE F-18

>D> AP UIHC PET IMAGING 10-200mCi/ML A 204462 001 Nov 17, 2015 Dec DISC

>A> @ 10-200mCi/ML A 204462 001 Nov 17, 2015 Dec DISC

SODIUM NITROPRUSSIDE

INJECTABLE;INJECTION

SODIUM NITROPRUSSIDE

>A> AP AMPHASTAR PHARMS INC 25MG/ML A 209832 001 Dec 18, 2017 Dec NEWA

SOLUTION;IV (INFUSION)

NIPRIDE RTU IN SODIUM CHLORIDE 0.9%

>A> +! EXELA PHARMA SCS LLC 10MG/50ML (0.2MG/ML) N 209387 002 Dec 07, 2017 Dec NEWA

TAZAROTENE

CREAM;TOPICAL

TAZAROTENE

>A> AB G AND W LABS INC 0.1% A 208662 001 Dec 22, 2017 Dec NEWA

>D> TELBIVUDINE

>D> TABLET;ORAL

>D> TYZEKA

>D> +! NOVARTIS 600MG N 022011 001 Oct 25, 2006 Dec DISC

>A> + @ 600MG N 022011 001 Oct 25, 2006 Dec DISC

TEMAZEPAM

CAPSULE;ORAL

RESTORIL

>D> AB + MALLINCKRODT INC 7.5MG N 018163 003 Oct 25, 1991 Dec CAHN

>D> AB + 15MG N 018163 001 Feb 27, 1981 Dec CAHN

>D> AB + 22.5MG N 018163 004 Nov 02, 2004 Dec CAHN

>D> AB +! 30MG N 018163 002 Feb 27, 1981 Dec CAHN

>A> AB + SPECGX LLC 7.5MG N 018163 003 Oct 25, 1991 Dec CAHN

>A> AB + 15MG N 018163 001 Feb 27, 1981 Dec CAHN

>A> AB + 22.5MG N 018163 004 Nov 02, 2004 Dec CAHN

>A> AB +! 30MG N 018163 002 Feb 27, 1981 Dec CAHN

TERBUTALINE SULFATE

TABLET;ORAL

TERBUTALINE SULFATE

>D> @ IMPAX LABS 2.5MG A 075877 001 Jun 26, 2001 Dec CMFD

>A> AB 2.5MG A 075877 001 Jun 26, 2001 Dec CMFD

>D> @ 5MG A 075877 002 Jun 26, 2001 Dec CMFD

>A> AB 5MG A 075877 002 Jun 26, 2001 Dec CMFD

>D> LANNETT 2.5MG A 077152 001 Mar 25, 2005 Dec CTEC

>A> AB 2.5MG A 077152 001 Mar 25, 2005 Dec CTEC

>D> ! 5MG A 077152 002 Mar 25, 2005 Dec CTEC

>A> AB ! 5MG A 077152 002 Mar 25, 2005 Dec CTEC

TERCONAZOLE

CREAM;VAGINAL

>D> TERAZOL 3

>D> AB +! JANSSEN PHARMS 0.8% N 019964 001 Feb 21, 1991 Dec DISC

>A> + @ 0.8% N 019964 001 Feb 21, 1991 Dec DISC

TERCONAZOLE

>D> AB TARO 0.8% A 075953 001 Apr 06, 2004 Dec CTEC

>A> BX ! 0.8% A 075953 001 Apr 06, 2004 Dec CTEC

TETRABENAZINE

TABLET;ORAL

TETRABENAZINE

>A> AB BIONPHARMA INC 12.5MG A 208826 001 Dec 18, 2017 Dec NEWA

>A> AB 25MG A 208826 002 Dec 18, 2017 Dec NEWA

>A> AB DR REDDYS LABS LTD 12.5MG A 209284 001 Jan 08, 2018 Dec NEWA

>A> AB 25MG A 209284 002 Jan 08, 2018 Dec NEWA

Page 25 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

THEOPHYLLINE

TABLET, EXTENDED RELEASE;ORAL

THEOCHRON

>A> NOSTRUM PHARMS LLC
100MG
A 087400 003 Feb 21, 1985 Dec CMS1

>A>
200MG
A 087400 004 Feb 21, 1985 Dec CMS1

TICLOPIDINE HYDROCHLORIDE

TABLET;ORAL

TICLOPIDINE HYDROCHLORIDE

>A> @ FOSUN PHARMA
250MG
A 075318 001 Aug 20, 1999 Dec CAHN

>A> @
250MG
A 075326 001 Aug 20, 1999 Dec CAHN

>D> @ SANDOZ
250MG
A 075318 001 Aug 20, 1999 Dec CAHN

>D> @
250MG
A 075326 001 Aug 20, 1999 Dec CAHN

TIMOLOL MALEATE

TABLET;ORAL

TIMOLOL MALEATE

>A> @ FOSUN PHARMA
5MG
A 072550 001 Apr 13, 1989 Dec CAHN

>A> @
10MG
A 072551 001 Apr 13, 1989 Dec CAHN

>A> @
20MG
A 072552 001 Apr 13, 1989 Dec CAHN

>D> @ SANDOZ
5MG
A 072550 001 Apr 13, 1989 Dec CAHN

>D> @
10MG
A 072551 001 Apr 13, 1989 Dec CAHN

>D> @
20MG
A 072552 001 Apr 13, 1989 Dec CAHN

TOLAZAMIDE

TABLET;ORAL

TOLAZAMIDE

>A> @ FOSUN PHARMA
250MG
A 070289 001 Mar 13, 1986 Dec CAHN

>A> @
500MG
A 070290 001 Mar 13, 1986 Dec CAHN

>D> @ SANDOZ
250MG
A 070289 001 Mar 13, 1986 Dec CAHN

>D> @
500MG
A 070290 001 Mar 13, 1986 Dec CAHN

TRAMADOL HYDROCHLORIDE

TABLET;ORAL

TRAMADOL HYDROCHLORIDE

>D> AB MALLINCKRODT
50MG
A 075983 001 Jun 25, 2002 Dec CAHN

>A> AB SPECGX LLC
50MG
A 075983 001 Jun 25, 2002 Dec CAHN

TRIAMCINOLONE ACETONIDE

CREAM;TOPICAL

TRIAMCINOLONE ACETONIDE

>A> AT ALKEM LABS LTD
0.025%
A 207651 001 Dec 26, 2017 Dec NEWA

>A> AT
0.1%
A 207651 002 Dec 26, 2017 Dec NEWA

>A> AT
0.5%
A 207651 003 Dec 26, 2017 Dec NEWA

LOTION;TOPICAL

TRIAMCINOLONE ACETONIDE

>D> AT ! WOCKHARDT
0.1%
A 088451 001 Apr 03, 1985 Dec CAHN

>A> AT ! WOCKHARDT BIO AG
0.025%
A 088450 001 Apr 01, 1985 Dec CAHN

>A> AT !
0.1%
A 088451 001 Apr 03, 1985 Dec CAHN

>D> AT ! WOCKHARDT EU OPERATN
0.025%
A 088450 001 Apr 01, 1985 Dec CAHN

TRIAMCINOLONE DIACETATE

INJECTABLE;INJECTION

ARISTOCORT

>A> @ FOSUN PHARMA
25MG/ML
N 011685 003 Mar 12, 1959 Dec CAHN

>A> + @
40MG/ML
N 012802 001 Sep 05, 1961 Dec CAHN

>D> @ SANDOZ INC
25MG/ML
N 011685 003 Mar 12, 1959 Dec CAHN

>D> + @
40MG/ML
N 012802 001 Sep 05, 1961 Dec CAHN

TRIMETHOPRIM HYDROCHLORIDE

SOLUTION;ORAL

PRIMSOL

>A> @ ALLEGIS
EQ 25MG BASE/5ML
N 074374 001 Jun 23, 1995 Dec CAHN

>D> @ AYTU PHARMS
EQ 25MG BASE/5ML
N 074374 001 Jun 23, 1995 Dec CAHN

Page 26 of 29

 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

VALACYCLOVIR HYDROCHLORIDE
TABLET;ORAL
VALACYCLOVIR HYDROCHLORIDE
>A> AB ZYDUS PHARMS USA INC EQ 500MG BASE A 079137 001 Dec 29, 2017 Dec NEWA
>A> AB EQ 1GM BASE A 079137 002 Dec 29, 2017 Dec NEWA

VALPROIC ACID
SYRUP;ORAL
VALPROIC ACID
>D> AA WOCKHARDT 250MG/5ML A 070868 001 Jul 01, 1986 Dec CAHN
>A> AA WOCKHARDT BIO AG 250MG/5ML A 070868 001 Jul 01, 1986 Dec CAHN

VALSARTAN
>A> SOLUTION;ORAL
>A> PREXXARTAN
>A> +! CARMEL BIOSCIENCES 20MG/5ML N 209139 001 Dec 19, 2017 Dec NEWA
>A> +! 80MG/20ML N 209139 002 Dec 19, 2017 Dec NEWA

VERAPAMIL HYDROCHLORIDE
TABLET;ORAL
VERAPAMIL HYDROCHLORIDE
>A> @ FOSUN PHARMA 40MG A 073168 001 Jul 31, 1992 Dec CAHN
>A> @ 80MG A 071423 001 May 24, 1988 Dec CAHN
>A> @ 120MG A 071424 001 May 25, 1988 Dec CAHN
>A> AB HERITAGE PHARMS INC 80MG A 071881 003 Apr 05, 1988 Dec CMS1
>D> @ SANDOZ 40MG A 073168 001 Jul 31, 1992 Dec CAHN
>D> @ 80MG A 071423 001 May 24, 1988 Dec CAHN
>D> @ 120MG A 071424 001 May 25, 1988 Dec CAHN

WARFARIN SODIUM
TABLET;ORAL
WARFARIN SODIUM
>A> @ FOSUN PHARMA 1MG A 040196 001 Sep 30, 1997 Dec CAHN
>A> @ 2MG A 040196 002 Sep 30, 1997 Dec CAHN
>A> @ 2.5MG A 040196 003 Sep 30, 1997 Dec CAHN
>A> @ 3MG A 040196 008 Jul 26, 2000 Dec CAHN
>A> @ 4MG A 040196 004 Sep 30, 1997 Dec CAHN
>A> @ 5MG A 040196 005 Sep 30, 1997 Dec CAHN
>A> @ 6MG A 040196 009 Jul 26, 2000 Dec CAHN
>A> @ 7.5MG A 040196 006 Sep 30, 1997 Dec CAHN
>A> @ 10MG A 040196 007 Sep 30, 1997 Dec CAHN
>D> @ SANDOZ 1MG A 040196 001 Sep 30, 1997 Dec CAHN
>D> @ 2MG A 040196 002 Sep 30, 1997 Dec CAHN
>D> @ 2.5MG A 040196 003 Sep 30, 1997 Dec CAHN
>D> @ 3MG A 040196 008 Jul 26, 2000 Dec CAHN
>D> @ 4MG A 040196 004 Sep 30, 1997 Dec CAHN
>D> @ 5MG A 040196 005 Sep 30, 1997 Dec CAHN
>D> @ 6MG A 040196 009 Jul 26, 2000 Dec CAHN
>D> @ 7.5MG A 040196 006 Sep 30, 1997 Dec CAHN
>D> @ 10MG A 040196 007 Sep 30, 1997 Dec CAHN

ZOLEDRONIC ACID
INJECTABLE;IV (INFUSION)
ZOLEDRONIC ACID
>A> AP BPI LABS LLC EQ 4MG BASE/5ML A 207341 001 Dec 29, 2017 Dec NEWA

ZOLPIDEM TARTRATE
TABLET;ORAL
ZOLPIDEM TARTRATE
>A> AB ACME LABS 5MG A 077214 001 Apr 23, 2007 Dec CAHN
>A> AB 10MG A 077214 002 Apr 23, 2007 Dec CAHN
>D> AB ALLIED PHARMA INC 5MG A 077214 001 Apr 23, 2007 Dec CAHN
>D> AB 10MG A 077214 002 Apr 23, 2007 Dec CAHN

Page 27 of 29

 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

BRIMONIDINE TARTRATE
SOLUTION/DROPS;OPHTHALMIC
>A> LUMIFY
>A> +! BAUSCH AND LOMB INC 0.025% N 208144 001 Dec 22, 2017 Dec NEWA

CETIRIZINE HYDROCHLORIDE
TABLET;ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
>A> GRANULES INDIA LTD 10MG A 209274 001 Dec 22, 2017 Dec NEWA

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE

TABLET, EXTENDED RELEASE;ORAL
GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
>A> DR REDDYS LABS LTD 600MG;60MG A 208369 001 Dec 29, 2017 Dec NEWA
>A> 1.2GM;120MG A 208369 002 Dec 29, 2017 Dec NEWA

IBUPROFEN
CAPSULE;ORAL
IBUPROFEN
>A> ASCENT PHARMS INC EQ 200MG FREE ACID AND A 206999 001 Dec 21, 2017 Dec NEWA
POTASSIUM SALT

LOPERAMIDE HYDROCHLORIDE
SOLUTION;ORAL
LOPERAMIDE HYDROCHLORIDE
>D> WOCKHARDT 1MG/5ML A 074730 001 Aug 28, 1997 Dec CAHN
>A> WOCKHARDT BIO AG 1MG/5ML A 074730 001 Aug 28, 1997 Dec CAHN

LORATADINE
SYRUP;ORAL
LORATADINE
>D> WOCKHARDT 1MG/ML A 075815 001 Aug 20, 2004 Dec CAHN
>A> WOCKHARDT BIO AG 1MG/ML A 075815 001 Aug 20, 2004 Dec CAHN

MINOXIDIL
SOLUTION;TOPICAL
MINOXIDIL (FOR MEN)
>D> WOCKHARDT 2% A 074767 001 Feb 28, 1997 Dec CAHN
>A> WOCKHARDT BIO AG 2% A 074767 001 Feb 28, 1997 Dec CAHN
MINOXIDIL EXTRA STRENGTH (FOR MEN)
>D> WOCKHARDT 5% A 075438 001 Feb 27, 2003 Dec CAHN
>A> WOCKHARDT BIO AG 5% A 075438 001 Feb 27, 2003 Dec CAHN

Page 28 of 29

CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference

Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval

date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB

Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A>

during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>.

The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month.

CAHN** Applicant holder firm name has changed.

CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the

old name and all products will be added under the changed ingredient(s) name.

CDFR Change. Dosage Form; Route of Administration.

CFTG Change. A first time generic for the innovator product. A TE Code is added.

CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status.

CMS1 Change. Miscellaneous addition to list.

CMS2 Change. Miscellaneous deletion from list.

CPOT Change. Potency amount/unit.

CRLD Change. Reference Listed Drug.

CHRS Change. Reference Standard.

CTEC Change. Therapeutic Equivalence Code.

CTNA Change. Trade Name.

DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the

discontinued section in the next edition.

**Note:

The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name

and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An

applicant holder firm name change usually changes both the collapsed name and long name. On accasion, only the

long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new

firm long name will display in the EOB query.

Page 29 of 29